Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
16000,,,18003836,[],CHEMBL4002963,Antibacterial activity against Escherichia coli after 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4002565,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2983423,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
16001,,,18006889,[],CHEMBL4003401,Permeability of compound at 100 ug/ml after 18 hrs by PAMPA,P,,,BAO_0002808,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4002586,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,2983894,=,1,0,=,,permeability,10'-6 cm/s,,0.42,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.42
16002,,,18006900,[],CHEMBL4003402,Permeability of compound at 25 ug/ml after 18 hrs by PAMPA,P,,,BAO_0002808,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4002586,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,2983894,=,1,0,=,,permeability,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.1
16003,,,18009335,[],CHEMBL4003895,Antibacterial activity against Streptococcus pneumoniae MTCC 1936 by broth microdilution assay method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4002605,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2984392,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,10.0
16004,,,18009415,[],CHEMBL4003896,Antibacterial activity against Bacillus subtilis MTCC 441 by broth microdilution assay method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4002605,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2984392,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
16005,,,18009458,[],CHEMBL4003897,Antibacterial activity against Clostridium tetani MTCC 449 by broth microdilution assay method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4002605,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2984392,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL613073,Clostridium tetani,Clostridium tetani,1513.0,,,MIC,ug ml-1,UO_0000274,,50.0
16006,,,18009501,[],CHEMBL4003898,Antibacterial activity against Escherichia coli MTCC 443 by broth microdilution assay method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4002605,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2984392,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
16007,,,18009544,[],CHEMBL4003899,Antibacterial activity against Salmonella typhi MTCC 98 by broth microdilution assay method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4002605,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2984392,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,10.0
16008,,,18009587,[],CHEMBL4003900,Antibacterial activity against Vibrio cholerae MTCC 3906 by broth microdilution assay method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4002605,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2984392,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,10.0
16009,,,18014395,[],CHEMBL4004497,Permeability of the compound in PBS/EtOH at 100 ug/ml after 18 hrs by PAMPA,P,,,BAO_0002808,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4002639,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,2985103,=,1,0,=,,permeability,ucm/s,,0.42,CHEMBL2362975,,No relevant target,,,,permeability,ucm/s,,,0.42
16010,,,18014406,[],CHEMBL4004498,Permeability of the compound by PAMPA,P,,,BAO_0002808,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4002639,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,2985103,=,1,0,=,,permeability,ucm/s,,0.1,CHEMBL2362975,,No relevant target,,,,permeability,ucm/s,,,0.1
16011,,,18052716,[],CHEMBL4011777,Permeability of the compound in PBS/EtOH at 100 ug/ml after 18 hrs by PAMPA-BBB assay,P,,,BAO_0002808,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4011587,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,2992007,=,1,0,=,,permeability,10'-6 cm/s,,0.42,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.42
16012,,,18052727,[],CHEMBL4011778,Effective permeability of the compound at pH 7.4 at 25 ug/ml after 18 hrs by PAMPA-BBB assay,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4011587,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,2992007,=,1,0,=,,Peff,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.1
16013,,,18061793,[],CHEMBL4013417,Ratio of MIC for Staphylococcus aureus ATCC 29213 after 15 passages to MIC for Staphylococcus aureus ATCC 29213,F,,,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4011638,J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,2993625,=,1,0,=,,Ratio,,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,128.0
16014,,,18129433,[],CHEMBL4028921,Inhibition of human BSEP overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-taurocholate in presence of ATP measured after 15 to 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3006771,>,1,1,>,,IC50,nM,,133000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,IC50,uM,UO_0000065,,133.0
16015,,,18130008,[],CHEMBL4028922,Inhibition of human MRP2 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3006771,>,1,1,>,,IC50,nM,,133000.0,CHEMBL5748,Homo sapiens,Canalicular multispecific organic anion transporter 1,9606.0,,,IC50,uM,UO_0000065,,133.0
16016,,,18130603,[],CHEMBL4028923,Inhibition of human MRP3 overexpressed in Sf9 insect cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 10 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3006771,>,1,1,>,,IC50,nM,,133000.0,CHEMBL5918,Homo sapiens,Canalicular multispecific organic anion transporter 2,9606.0,,,IC50,uM,UO_0000065,,133.0
16017,,,18131203,[],CHEMBL4028924,Inhibition of human MRP4 overexpressed in Sf9 cell membrane vesicles assessed as uptake of [3H]-estradiol-17beta-D-glucuronide in presence of ATP and GSH measured after 20 mins by membrane vesicle transport assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4028801,Toxicol Sci,2013.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3006771,>,1,1,>,,IC50,nM,,133000.0,CHEMBL1743128,Homo sapiens,Multidrug resistance-associated protein 4,9606.0,,,IC50,uM,UO_0000065,,133.0
16018,,,18132006,[],CHEMBL4029349,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index,T,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3007004,=,1,0,=,,DILI_severity_class,,,3.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_severity_class,,,,3.0
16019,,Less-Dili-Concern,18132606,[],CHEMBL4029350,Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status,T,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4028802,Drug Discov Today,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3007004,,1,0,,,DILI_Concern,,,,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,DILI_Concern,,,,
16020,,,18158422,[],CHEMBL4035435,Effective permeability of the compound at 100 ug/ml incubated for 18 hrs by PAMPA-BBB assay,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4033676,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3012343,=,1,0,=,,Peff,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,0.42,0.1
16021,,,18173169,[],CHEMBL4038355,Antibacterial activity against Bacillus amyloliquefaciens at 25 ug/ml after 24 hrs by plate colony counting method relative to control,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4038262,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3015204,=,1,1,=,,Inhibition,%,,84.0,CHEMBL4630665,Bacillus amyloliquefaciens,Bacillus amyloliquefaciens,1390.0,,,INH,%,UO_0000187,,84.0
16022,,,18173212,[],CHEMBL4038356,Antibacterial activity against Staphylococcus aureus at 25 ug/ml after 24 hrs by plate colony counting method relative to control,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4038262,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3015204,=,1,1,=,,Inhibition,%,,78.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,INH,%,UO_0000187,,78.0
16023,,,18173238,[],CHEMBL4038357,Antibacterial activity against Bacillus subtilis at 25 ug/ml after 24 hrs by plate colony counting method relative to control,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4038262,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3015204,=,1,1,=,,Inhibition,%,,89.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,INH,%,UO_0000187,,89.0
16024,,,18173247,[],CHEMBL4038358,Antibacterial activity against Bacillus amyloliquefaciens after 24 hrs by plate colony counting method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4038262,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3015204,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL4630665,Bacillus amyloliquefaciens,Bacillus amyloliquefaciens,1390.0,,,MIC,ug ml-1,UO_0000274,,25.0
16025,,,18173256,[],CHEMBL4038359,Antibacterial activity against Staphylococcus aureus after 24 hrs by plate colony counting method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4038262,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3015204,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,25.0
16026,,,18173265,[],CHEMBL4038360,Antibacterial activity against Bacillus subtilis after 24 hrs by plate colony counting method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4038262,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3015204,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,25.0
16027,,,18210530,[],CHEMBL4045511,Antimicrobial activity against Staphylococcus aureus MTCC 96,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4043157,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3021395,=,1,1,=,,MIC,nM,,31000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.031
16028,,,18210555,[],CHEMBL4045512,Antimicrobial activity against Streptococcus pyogenes MTCC 442,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4043157,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3021395,=,1,1,=,,MIC,nM,,31000.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mM,UO_0000065,,0.031
16029,,,18210571,[],CHEMBL4045513,Antimicrobial activity against Escherichia coli MTCC 443,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4043157,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3021395,=,1,1,=,,MIC,nM,,31000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.031
16030,,,18210587,[],CHEMBL4045514,Antimicrobial activity against Pseudomonas aeruginosa MTCC 1688,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4043157,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3021395,=,1,1,=,,MIC,nM,,31000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.031
16031,,Not Determined,18210603,[],CHEMBL4045515,Antimicrobial activity against Candida albicans MTCC 227,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4043157,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3021395,,1,0,,,MIC,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,,,,
16032,,Not Determined,18210619,[],CHEMBL4045516,Antimicrobial activity against Aspergillus clavatus MTCC 1323,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4043157,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3021395,,1,0,,,MIC,,,,CHEMBL2367179,Aspergillus clavatus,Aspergillus clavatus,5057.0,,,MIC,,,,
16033,,,18223073,[],CHEMBL4048094,Effective permeability of the compound at 100 ug/ml by PAMPA-BBB assay,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4043275,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3023963,=,1,0,=,,Peff,10'-6 cm/s,,0.42,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.42
16034,,,18223225,[],CHEMBL4048115,Effective permeability of the compound by PAMPA,P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4043276,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3024000,=,1,0,=,,Peff,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,0.42,0.1
16035,,,18233590,[],CHEMBL4050674,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by two-fold serial dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4049410,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3025829,=,1,1,=,,MIC,nM,,25100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,25.1
16036,,,18233617,[],CHEMBL4050675,Antibacterial activity against Bacillus subtilis after 24 hrs by two-fold serial dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4049410,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3025829,=,1,1,=,,MIC,nM,,3100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,uM,UO_0000065,,3.1
16037,,,18233644,[],CHEMBL4050676,Antibacterial activity against Micrococcus luteus ATCC 4698 after 24 hrs by two-fold serial dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4049410,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3025829,=,1,1,=,,MIC,nM,,4200.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,uM,UO_0000065,,4.2
16038,,,18233671,[],CHEMBL4050677,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by two-fold serial dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4049410,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3025829,=,1,1,=,,MIC,nM,,1100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,1.1
16039,,,18233698,[],CHEMBL4050678,Antibacterial activity against Escherichia coli JM109 after 24 hrs by two-fold serial dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4049410,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3025829,=,1,1,=,,MIC,nM,,50100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,50.1
16040,,,18233725,[],CHEMBL4050679,Antibacterial activity against Escherichia coli DH52 after 24 hrs by two-fold serial dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4049410,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3025829,=,1,1,=,,MIC,nM,,50100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,50.1
16041,,,18233752,[],CHEMBL4050680,Antibacterial activity against Shigella dysenteriae after 24 hrs by two-fold serial dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4049410,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3025829,=,1,1,=,,MIC,nM,,5300.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC,uM,UO_0000065,,5.3
16042,,,18233779,[],CHEMBL4050681,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by two-fold serial dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4049410,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3025829,=,1,1,=,,MIC,nM,,41800.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,41.8
16043,,,18233806,[],CHEMBL4050682,Antibacterial activity against Bacillus typhi after 24 hrs by two-fold serial dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4049410,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3025829,=,1,1,=,,MIC,nM,,10400.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,uM,UO_0000065,,10.4
16044,,,18233833,[],CHEMBL4050683,Antibacterial activity against Bacillus proteus ATCC 13315 after 24 hrs by two-fold serial dilution assay,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4049410,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3025829,=,1,1,=,,MIC,nM,,12500.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,uM,UO_0000065,,12.5
16045,,,18245700,[],CHEMBL4053351,Ratio of MIC for Staphylococcus aureus ATCC 29213 after and before 15 serial passages,F,,,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4052597,J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3027670,=,1,0,=,,Ratio,,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,128.0
16046,,,18259072,[],CHEMBL4056206,Antimicrobial activity against Staphylococcus aureus MTCC 96 incubated for overnight by broth micro dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4052693,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Millimolar,3030109,=,1,0,=,,MIC99,mM,,0.031,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC99,mM,UO_0000063,,0.031
16047,,,18259090,[],CHEMBL4056205,Antimicrobial activity against Streptococcus pyogenes MTCC 442 incubated for overnight by broth micro dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4052693,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Millimolar,3030109,=,1,0,=,,MIC99,mM,,0.031,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC99,mM,UO_0000063,,0.031
16048,,,18259108,[],CHEMBL4056207,Antimicrobial activity against Escherichia coli MTCC 443 incubated for overnight by broth micro dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4052693,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Millimolar,3030109,=,1,0,=,,MIC99,mM,,0.031,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC99,mM,UO_0000063,,0.031
16049,,,18259126,[],CHEMBL4056208,Antimicrobial activity against Pseudomonas aeruginosa MTCC 1688 incubated for overnight by broth micro dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4052693,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Millimolar,3030109,=,1,0,=,,MIC99,mM,,0.031,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC99,mM,UO_0000063,,0.031
16050,,Not Determined,18259144,[],CHEMBL4056209,Antifungal activity against Candida albicans MTCC 227 incubated for overnight by broth micro dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4052693,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3030109,,1,0,,,MIC99,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC99,,,,
16051,,Not Determined,18259162,[],CHEMBL4056210,Antifungal activity against Aspergillus clavatus MTCC 1323 incubated for overnight by broth micro dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4052693,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3030109,,1,0,,,MIC99,,,,CHEMBL2367179,Aspergillus clavatus,Aspergillus clavatus,5057.0,,,MIC99,,,,
16052,,,18291742,[],CHEMBL4122775,Effective permeability of the compound in PBS/EtOH at 50 ug/mL after 18 hrs by PAMPA-BBB assay,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118162,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3036323,=,1,0,=,,Peff,10'-6 cm/s,,0.42,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.42
16053,,,18291753,[],CHEMBL4122776,Effective permeability of the compound by PAMPA-BBB assay,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118162,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3036323,=,1,0,=,,Peff,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.1
16054,,,18304686,[],CHEMBL4125485,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118281,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038709,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16055,,,18304712,[],CHEMBL4125486,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118281,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038709,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16056,,,18304738,[],CHEMBL4125487,Antibacterial activity against Bacillus subtilis after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118281,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038709,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,4.0
16057,,,18304764,[],CHEMBL4125488,Antibacterial activity against Micrococcus luteus ATCC 4698 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118281,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038709,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
16058,,,18304790,[],CHEMBL4125489,Antibacterial activity against Escherichia coli DH52 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118281,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038709,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16059,,,18304816,[],CHEMBL4125490,Antibacterial activity against Escherichia coli JM109 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118281,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038709,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16060,,,18304842,[],CHEMBL4125491,Antibacterial activity against Shigella dysenteriae after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118281,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038709,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC,ug ml-1,UO_0000274,,16.0
16061,,,18304868,[],CHEMBL4125492,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118281,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038709,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
16062,,,18304894,[],CHEMBL4125493,Antibacterial activity against Bacillus proteus ATCC 13315 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118281,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038709,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,,MIC,ug ml-1,UO_0000274,,8.0
16063,,,18304920,[],CHEMBL4125494,Antibacterial activity against Bacillus typhi after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4118281,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3038709,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,4.0
16064,,,18328910,[],CHEMBL4135953,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate EMRSA-15 after 24 hrs by MTT dye based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4130543,J Nat Prod,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043273,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16065,,,18328913,[],CHEMBL4135952,Antibacterial activity against methicillin-resistant Staphylococcus aureus RN4220 after 24 hrs by MTT dye based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4130543,J Nat Prod,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043273,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16066,,,18328916,[],CHEMBL4135951,Antibacterial activity against methicillin-resistant Staphylococcus aureus SA1199B after 24 hrs by MTT dye based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4130543,J Nat Prod,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043273,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
16067,,,18328919,[],CHEMBL4135950,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate XU2120 after 24 hrs by MTT dye based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4130543,J Nat Prod,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043273,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16068,,,18328922,[],CHEMBL4135949,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 after 24 hrs by MTT dye based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4130543,J Nat Prod,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3043273,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16069,,,18330230,[],CHEMBL4136125,Ratio of MIC for Staphylococcus aureus ATCC 29213 after 20 serial passages to MIC for Staphylococcus aureus ATCC 29213,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4130549,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3043374,=,1,0,=,,Ratio,,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,256.0
16070,,,18342339,[],CHEMBL4139042,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by NCCLS two fold broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138085,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3045954,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16071,,,18342415,[],CHEMBL4139043,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by NCCLS two fold broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138085,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3045954,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16072,,,18342454,[],CHEMBL4139044,Antibacterial activity against Bacillus subtilis ATCC 21216 after 24 hrs by NCCLS two fold broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138085,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3045954,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,2.0
16073,,,18342493,[],CHEMBL4139045,Antibacterial activity against Micrococcus luteus ATCC 4698 after 24 hrs by NCCLS two fold broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138085,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3045954,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,1.0
16074,,,18342532,[],CHEMBL4139046,Antibacterial activity against Bacillus proteus ATCC 13315 after 24 hrs by NCCLS two fold broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138085,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3045954,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,,MIC,ug ml-1,UO_0000274,,4.0
16075,,,18342571,[],CHEMBL4139047,Antibacterial activity against Escherichia coli ATCC 8099 after 24 hrs by NCCLS two fold broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138085,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3045954,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16076,,,18342610,[],CHEMBL4139048,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by NCCLS two fold broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138085,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3045954,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
16077,,,18342649,[],CHEMBL4139049,Antibacterial activity against Bacillus typhi after 24 hrs by NCCLS two fold broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138085,Eur J Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3045954,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,1.0
16078,,,18360608,[],CHEMBL4141678,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138157,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3047430,=,1,1,=,,MIC,nM,,3914300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,3914.3
16079,,,18360633,[],CHEMBL4141679,Antibacterial activity against Streptococcus pyogenes ATCC 19615 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138157,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3047430,=,1,1,=,,MIC,nM,,1957200.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,uM,UO_0000065,,1957.2
16080,,,18360658,[],CHEMBL4141680,Antibacterial activity against Salmonella typhi ATCC 19430 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138157,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3047430,=,1,1,=,,MIC,nM,,7500.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,uM,UO_0000065,,7.5
16081,,,18360683,[],CHEMBL4141677,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138157,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3047430,=,1,1,=,,MIC,nM,,15000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,15.0
16082,,Not Determined,18360708,[],CHEMBL4141681,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138157,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3047430,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
16083,,,18362415,[],CHEMBL4142033,Antibacterial activity against Enterococcus faecalis NCTC 12697 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3047785,=,1,1,=,,MIC,nM,,6300.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,6.3
16084,,Not Determined,18362450,[],CHEMBL4142034,Antibacterial activity against Bacillus subtilis NCTC 10400 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3047785,,1,0,,,MIC,,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,,,,
16085,,Not Determined,18362485,[],CHEMBL4142035,Antibacterial activity against methicillin-sensitive Staphylococcus aureus NCTC 12981 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3047785,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
16086,,Not Determined,18362520,[],CHEMBL4142036,Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 13373 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3047785,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
16087,,,18362555,[],CHEMBL4142037,Antibacterial activity against Norfloxacin-resistant Staphylococcus aureus 1199B over-expressing NorA after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3047785,=,1,1,=,,MIC,nM,,106000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,106.0
16088,,,18362590,[],CHEMBL4142038,Antibacterial activity against erythromycin-resistant Staphylococcus aureus RN4220 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3047785,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
16089,,,18362625,[],CHEMBL4142039,Antibacterial activity against Staphylococcus aureus EMRSA-15 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3047785,=,1,1,=,,MIC,nM,,3300.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,3.3
16090,,,18362660,[],CHEMBL4142040,Antibacterial activity against tetracycline/methicillin-resistant Staphylococcus aureus XU212 after 16 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138171,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3047785,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
16091,,,18372019,[],CHEMBL4143626,Ratio of MIC for Staphylococcus aureus ATCC 29213 after 20 passages to MIC for Staphylococcus aureus ATCC 29213 before 20 passages,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138242,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3049427,=,1,0,=,,Ratio,,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,256.0
16092,,,18374511,[],CHEMBL4144217,Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138260,ACS Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3049779,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16093,,,18374518,[],CHEMBL4144218,Antimicrobial activity against Acinetobacter baumannii after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138260,ACS Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3049779,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
16094,,,18375952,[],CHEMBL4144613,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 25923 after 18 hrs by MTT based broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138281,J Nat Prod,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3050057,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
16095,,,18375997,[],CHEMBL4144617,Antimicrobial activity against methicillin-resistant Staphylococcus aureus EMRSA-15 after 18 hrs by MTT based broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138281,J Nat Prod,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3050057,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
16096,,Not Determined,18376008,[],CHEMBL4144616,Antimicrobial activity against methicillin-resistant Staphylococcus aureus RN4220 after 18 hrs by MTT based broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138281,J Nat Prod,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3050057,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
16097,,,18376019,[],CHEMBL4144615,Antimicrobial activity against methicillin-resistant Staphylococcus aureus SA1199B after 18 hrs by MTT based broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138281,J Nat Prod,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3050057,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
16098,,,18376030,[],CHEMBL4144614,Antimicrobial activity against tetracycline/methicillin-resistant Staphylococcus aureus XU212 after 18 hrs by MTT based broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4138281,J Nat Prod,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3050057,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
16099,,,18388364,[],CHEMBL4147307,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by CLSI two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4145497,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3052097,=,1,1,=,,MIC,nM,,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/ml,UO_0000065,,0.002
16100,,,18388403,[],CHEMBL4147308,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 18 to 24 hrs by CLSI two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4145497,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3052097,=,1,1,=,,MIC,nM,,30000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/ml,UO_0000065,,0.03
16101,,,18388445,[],CHEMBL4147309,Antibacterial activity against Bacillus subtilis ATCC 21216 after 18 to 24 hrs by CLSI two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4145497,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3052097,=,1,1,=,,MIC,nM,,3000.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,umol/ml,UO_0000065,,0.003
16102,,,18388487,[],CHEMBL4147310,Antibacterial activity against Micrococcus luteus ATCC 4698 after 18 to 24 hrs by CLSI two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4145497,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3052097,=,1,1,=,,MIC,nM,,6000.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,umol/ml,UO_0000065,,0.006
16103,,,18388509,[],CHEMBL4147311,Antibacterial activity against drug-resistant Enterococcus faecalis after 18 to 24 hrs by CLSI two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4145497,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3052097,=,1,1,=,,MIC,nM,,800000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,umol/ml,UO_0000065,,0.8
16104,,,18388551,[],CHEMBL4147312,Antibacterial activity against Escherichia coli DH52 after 18 to 24 hrs by CLSI two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4145497,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3052097,=,1,1,=,,MIC,nM,,50000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/ml,UO_0000065,,0.05
16105,,,18388573,[],CHEMBL4147313,Antibacterial activity against drug-resistant Escherichia coli after 18 to 24 hrs by CLSI two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4145497,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3052097,=,1,1,=,,MIC,nM,,1600000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/ml,UO_0000065,,1.6
16106,,,18388615,[],CHEMBL4147314,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by CLSI two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4145497,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3052097,=,1,1,=,,MIC,nM,,50000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/ml,UO_0000065,,0.05
16107,,,18388637,[],CHEMBL4147315,Antibacterial activity against drug-resistant Pseudomonas aeruginosa after 18 to 24 hrs by CLSI two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4145497,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3052097,=,1,1,=,,MIC,nM,,1600000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/ml,UO_0000065,,1.6
16108,,,18388659,[],CHEMBL4147316,Antibacterial activity against drug-resistant Klebsiella pneumoniae after 18 to 24 hrs by CLSI two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4145497,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3052097,=,1,1,=,,MIC,nM,,800000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,umol/ml,UO_0000065,,0.8
16109,,,18388681,[],CHEMBL4147317,Antibacterial activity against drug-resistant Acinetobacter baumannii after 18 to 24 hrs by CLSI two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4145497,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3052097,=,1,1,=,,MIC,nM,,800000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,umol/ml,UO_0000065,,0.8
16110,,,18432034,[],CHEMBL4155868,Antibacterial activity against Staphylococcus aureus SA1199B over-expressing NorA by MTT dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4152298,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3059024,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
16111,,,18432064,[],CHEMBL4155869,Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate XU212 harboring TetK tetracycline efflux pump by MTT dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4152298,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3059024,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,8.0
16112,,,18432083,[],CHEMBL4155870,Antibacterial activity against Staphylococcus aureus ATCC 25923 by MTT dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4152298,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3059024,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
16113,,,18432102,[],CHEMBL4155871,Antibacterial activity against Staphylococcus aureus RN4220 harboring MsrA macrolide efflux protein by MTT dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4152298,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3059024,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
16114,,,18432121,[],CHEMBL4155872,Antibacterial activity against methicillin-resistant Staphylococcus aureus EMRSA15 by MTT dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4152298,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3059024,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
16115,,,18432140,[],CHEMBL4155873,Antibacterial activity against methicillin-resistant Staphylococcus aureus EMRSA16 by MTT dye based assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4152298,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3059024,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,256.0
16116,,,18456348,[],CHEMBL4179501,Antibacterial activity against Bacillus subtilis MTCC 441 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177593,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3063028,=,1,1,=,,MIC,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,100.0
16117,,,18456350,[],CHEMBL4179501,Antibacterial activity against Bacillus subtilis MTCC 441 by broth microdilution method,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4177593,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3063028,=,1,1,=,,IC50,ug.mL-1,,100.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IC50,ug ml-1,UO_0000274,,100.0
16118,,,18462395,[],CHEMBL4180930,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177646,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3064074,=,1,1,=,,MIC,nM,,1600000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/ml,UO_0000065,,1.6
16119,,,18462419,[],CHEMBL4180931,Antibacterial activity against drug-resistant Staphylococcus aureus after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177646,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3064074,=,1,1,=,,MIC,nM,,200000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/ml,UO_0000065,,0.2
16120,,,18462443,[],CHEMBL4180932,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177646,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3064074,=,1,1,=,,MIC,nM,,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/ml,UO_0000065,,0.1
16121,,,18462467,[],CHEMBL4180933,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177646,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3064074,=,1,1,=,,MIC,nM,,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/ml,UO_0000065,,0.025
16122,,,18462491,[],CHEMBL4180934,Antibacterial activity against drug-resistant Escherichia coli after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177646,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3064074,=,1,1,=,,MIC,nM,,1600000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/ml,UO_0000065,,1.6
16123,,,18462515,[],CHEMBL4180935,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177646,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3064074,=,1,1,=,,MIC,nM,,50000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/ml,UO_0000065,,0.05
16124,,,18462539,[],CHEMBL4180936,Antibacterial activity against drug-resistant Pseudomonas aeruginosa after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177646,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3064074,=,1,1,=,,MIC,nM,,1600000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/ml,UO_0000065,,1.6
16125,,,18462563,[],CHEMBL4180937,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177646,Bioorg Med Chem,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3064074,=,1,1,=,,MIC,nM,,1600000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/ml,UO_0000065,,1.6
16126,,,18467780,[],CHEMBL4182072,Antibacterial activity against Staphylococcus aureus measured after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177696,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3065267,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.6
16127,,,18467868,[],CHEMBL4182073,Antibacterial activity against Bacillus subtilis measured after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177696,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3065267,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.6
16128,,,18467956,[],CHEMBL4182074,Antibacterial activity against Escherichia coli measured after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177696,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3065267,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,3.1
16129,,,18468044,[],CHEMBL4182075,Antibacterial activity against Pseudomonas fluorescens measured after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177696,Bioorg Med Chem Lett,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3065267,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL612500,Pseudomonas fluorescens,Pseudomonas fluorescens,294.0,,,MIC,ug ml-1,UO_0000274,,1.6
16130,,,18471074,[],CHEMBL4182646,Antibacterial activity against Staphylococcus aureus MTCC 96 at 1 ug/ml under overnight incubation condition by paper disc method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177727,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3065876,=,1,1,=,,IZ,mm,,7.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,7.0
16131,,,18471118,[],CHEMBL4182645,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 at 1 ug/ml under overnight incubation condition by paper disc method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4177727,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3065876,=,1,1,=,,IZ,mm,,9.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,9.5
16132,,,18496237,[],CHEMBL4188381,Effective permeability of the compound in pH 7.4 buffer after 18 hrs by PAMPA-BBB assay,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4184259,Bioorg Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3070175,=,1,0,=,,Peff,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.1
16133,,,18496250,[],CHEMBL4188382,Effective permeability of the compound in PBS/EtOH at 100 ug/ml after 18 hrs by PAMPA-BBB assay,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4184259,Bioorg Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3070175,=,1,0,=,,Peff,10'-6 cm/s,,0.33,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.33
16134,,,18498328,[],CHEMBL4188678,Effective permeability of the compound at 200 uM after 5 hrs by PAMPA,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4184284,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3070640,=,1,0,=,,Peff,ucm/s,,0.95,CHEMBL2362975,,No relevant target,,,,Peff,ucm/s,,,0.95
16135,,,18547166,[],CHEMBL4198598,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by NCCLS micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4196079,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079296,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16136,,,18547191,[],CHEMBL4198597,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by NCCLS micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4196079,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079296,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16137,,,18547232,[],CHEMBL4198604,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by NCCLS micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4196079,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079296,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
16138,,,18547257,[],CHEMBL4198605,Antibacterial activity against Salmonella typhi after 24 hrs by NCCLS micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4196079,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079296,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,4.0
16139,,,18547266,[],CHEMBL4198602,Antibacterial activity against Escherichia coli JM109 after 24 hrs by NCCLS micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4196079,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079296,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16140,,,18547291,[],CHEMBL4198603,Antibacterial activity against Shigella dysenteriae after 24 hrs by NCCLS micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4196079,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079296,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC,ug ml-1,UO_0000274,,16.0
16141,,,18547300,[],CHEMBL4198600,Antibacterial activity against Micrococcus luteus ATCC 4698 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4196079,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079296,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
16142,,,18547325,[],CHEMBL4198599,Antibacterial activity against Bacillus subtilis ATCC 21216 after 24 hrs by NCCLS micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4196079,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079296,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,4.0
16143,,,18547368,[],CHEMBL4198601,Antibacterial activity against Escherichia coli DH52 after 24 hrs by NCCLS micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4196079,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079296,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16144,,,18547410,[],CHEMBL4198606,Antibacterial activity against Bacillus proteus ATCC 13315 after 24 hrs by NCCLS micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4196079,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3079296,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,,MIC,ug ml-1,UO_0000274,,8.0
16145,,,18574285,[],CHEMBL4221603,Effective permeability of the compound at 100 ug/ml after 18 hrs by PAMPA-BBB assay,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219111,Bioorg Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3084219,=,1,0,=,,Peff,10'-6 cm/s,,0.42,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.42
16146,,,18574297,[],CHEMBL4221605,Effective permeability of the compound at 25 ug/ml after 18 hrs by PAMPA-BBB assay,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219111,Bioorg Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3084219,=,1,0,=,,Peff,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.1
16147,,,18582530,[],CHEMBL4222941,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,512.0
16148,,,18582558,[],CHEMBL4222942,Antibacterial activity against Enterococcus faecalis after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,256.0
16149,,,18582586,[],CHEMBL4222943,Antibacterial activity against Staphylococcus aureus after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
16150,,,18582614,[],CHEMBL4222944,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
16151,,,18582642,[],CHEMBL4222945,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16152,,,18582670,[],CHEMBL4222946,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,>,1,1,>,,MIC,ug.mL-1,,512.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,512.0
16153,,,18582698,[],CHEMBL4222947,Antibacterial activity against Escherichia coli after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
16154,,,18582726,[],CHEMBL4222948,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
16155,,,18582754,[],CHEMBL4222949,Antibacterial activity against Acinetobacter baumannii after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,32.0
16156,,,18582782,[],CHEMBL4222950,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,512.0
16157,,,18582810,[],CHEMBL4222951,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4219183,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3085925,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16158,,,18663126,[],CHEMBL4232541,Dark toxicity against human MCF7 cells assessed as decrease in cell viability by MTT assay,T,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4229395,Bioorg Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.86,0,http://www.openphacts.org/units/Nanomolar,3099497,=,1,1,=,,IC50,nM,,13800.0,CHEMBL612558,,ADMET,,,,IC50,uM,UO_0000065,,13.8
16159,,,18688140,[],CHEMBL4252692,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by micro broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251572,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16160,,,18688181,[],CHEMBL4252693,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by micro broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251572,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16161,,,18688222,[],CHEMBL4252694,Antibacterial activity against Bacillus subtilis after 24 hrs by micro broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251572,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,2.0
16162,,,18688263,[],CHEMBL4252695,Antibacterial activity against Micrococcus luteus ATCC4698 after 24 hrs by micro broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251572,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,1.0
16163,,,18688304,[],CHEMBL4252696,Antibacterial activity against Bacillus proteus ATCC 13315 after 24 hrs by micro broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251572,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612428,Bacillus,Bacillus,1386.0,,,MIC,ug ml-1,UO_0000274,,4.0
16164,,,18688345,[],CHEMBL4252697,Antibacterial activity against Escherichia coli DH52 after 24 hrs by micro broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251572,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16165,,,18688386,[],CHEMBL4252698,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by micro broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251572,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
16166,,,18688427,[],CHEMBL4252699,Antibacterial activity against Bacillus typhi after 24 hrs by micro broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251572,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,1.0
16167,,,18688468,[],CHEMBL4252700,Antibacterial activity against Escherichia coli JM109 after 24 hrs by micro broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251572,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16168,,,18688509,[],CHEMBL4252701,Antibacterial activity against Shigella dysenteriae after 24 hrs by micro broth dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251572,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104064,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC,ug ml-1,UO_0000274,,16.0
16169,,Not Active,18688741,[],CHEMBL4252710,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 16 serial passages by two-fold serial dilution assay,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251572,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3104064,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16170,,,18690705,[],CHEMBL4253109,Antibacterial activity against Staphylococcus epidermidis after 18 hrs by agar dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251589,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104378,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,1.0,0.25
16171,,,18690708,[],CHEMBL4253108,Antibacterial activity against Staphylococcus aureus ATCC 6538P after 18 hrs by agar dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251589,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104378,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,1.0,0.25
16172,,,18690725,[],CHEMBL4253102,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251589,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3104378,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,39.06,0.02
16173,,,18693142,[],CHEMBL4253347,Antibacterial activity against Flavobacterium columnare FC-G1 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251599,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3104686,=,1,1,=,,MIC,nM,,32000.0,CHEMBL4296571,Flavobacterium columnare,Flavobacterium columnare,996.0,,,MIC,uM,UO_0000065,,32.0
16174,,,18693183,[],CHEMBL4253348,Antibacterial activity against Escherichia coli ATCC 35150 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251599,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3104686,=,1,1,=,,MIC,nM,,1000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,1.0
16175,,,18693219,[],CHEMBL4253349,Antibacterial activity against Streptococcus agalactiae WB1445 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251599,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3104686,=,1,1,=,,MIC,nM,,64000.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,uM,UO_0000065,,64.0
16176,,,18693260,[],CHEMBL4253350,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251599,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3104686,=,1,1,=,,MIC,nM,,32000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,32.0
16177,,,18693296,[],CHEMBL4253351,Bactericidal activity against Flavobacterium columnare FC-G1 incubated for 24 hrs followed by re-plating on nutrient agar and measured after overnight incubation by two fold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251599,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Micromolar,3104686,=,1,0,=,,MBC,uM,,128.0,CHEMBL4296571,Flavobacterium columnare,Flavobacterium columnare,996.0,,,MBC,uM,UO_0000064,,128.0
16178,,,18693337,[],CHEMBL4253352,Bactericidal activity against Escherichia coli ATCC 35150 incubated for 24 hrs followed by re-plating on nutrient agar and measured after overnight incubation by two fold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251599,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Micromolar,3104686,=,1,0,=,,MBC,uM,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,uM,UO_0000064,,2.0
16179,,,18693373,[],CHEMBL4253353,Bactericidal activity against Streptococcus agalactiae WB1445 incubated for 24 hrs followed by re-plating on nutrient agar and measured after overnight incubation by two fold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251599,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Micromolar,3104686,=,1,0,=,,MBC,uM,,128.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MBC,uM,UO_0000064,,128.0
16180,,,18693414,[],CHEMBL4253354,Bactericidal activity against Staphylococcus aureus ATCC 29213 incubated for 24 hrs followed by re-plating on nutrient agar and measured after overnight incubation by two fold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251599,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Micromolar,3104686,=,1,0,=,,MBC,uM,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM,UO_0000064,,64.0
16181,,,18701693,[],CHEMBL4255025,Permeability of the compound by PAMPA,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251652,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3105927,=,1,0,=,,permeability,ucm/s,,0.9,CHEMBL2362975,,No relevant target,,,,permeability,ucm/s,,,0.9
16182,,,18701704,[],CHEMBL4255026,Permeability of the compound at 500 uM after 8 hrs by PAMPA,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251652,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3105927,=,1,0,=,,permeability,ucm/s,,0.1,CHEMBL2362975,,No relevant target,,,,permeability,ucm/s,,,0.1
16183,,Active,18705475,[],CHEMBL4255881,Antimicrobial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by two-fold serial dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251702,ACS Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3106613,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16184,,Active,18705498,[],CHEMBL4255879,Antimicrobial activity against Enterococcus faecalis after 24 hrs by two-fold serial dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251702,ACS Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3106613,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
16185,,Active,18705597,[],CHEMBL4255887,Antimicrobial activity against Escherichia coli ATCC 25922 after 24 hrs by two-fold serial dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251702,ACS Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3106613,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
16186,,,18705603,[],CHEMBL4255891,Antimicrobial activity against Enterococcus faecalis assessed as ratio of MIC after and before 7 serial passages measured at 24 hrs interval for 16 days by two-fold serial dilution method,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4251702,ACS Med Chem Lett,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3106613,=,1,0,=,,Ratio,,,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Ratio,,,,16.0
16187,,,18730825,[],CHEMBL4260148,Antibacterial activity against methicillin resistant Staphylococcus aureus after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4257553,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16188,,,18730844,[],CHEMBL4260149,Antibacterial activity against Staphylococcus aureus after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4257553,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
16189,,,18730863,[],CHEMBL4260150,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4257553,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16190,,,18730882,[],CHEMBL4260151,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4257553,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16191,,,18730901,[],CHEMBL4260152,Antibacterial activity against Enterococcus faecalis after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4257553,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
16192,,,18730920,[],CHEMBL4260153,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4257553,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16193,,,18730939,[],CHEMBL4260154,Antibacterial activity against Escherichia coli after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4257553,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
16194,,,18730958,[],CHEMBL4260155,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4257553,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16195,,,18730977,[],CHEMBL4260156,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4257553,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16196,,,18730996,[],CHEMBL4260157,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4257553,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
16197,,,18731015,[],CHEMBL4260158,Antibacterial activity against Acinetobacter baumannii after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4257553,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3111862,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
16198,,,18740099,[],CHEMBL4262098,Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4261494,Medchemcomm,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,,MIC,ug ml-1,UO_0000274,,4.0
16199,,,18740117,[],CHEMBL4262099,Antibacterial activity against Micrococcus luteus ATCC 4698 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4261494,Medchemcomm,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,4.0
16200,,,18740140,[],CHEMBL4262097,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4261494,Medchemcomm,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16201,,,18740158,[],CHEMBL4262096,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4261494,Medchemcomm,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
16202,,,18740185,[],CHEMBL4262100,Antibacterial activity against Escherichia coli JM109 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4261494,Medchemcomm,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16203,,,18740203,[],CHEMBL4262101,Antibacterial activity against Escherichia coli DH52 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4261494,Medchemcomm,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16204,,,18740221,[],CHEMBL4262102,Antibacterial activity against Shigella dysenteriae after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4261494,Medchemcomm,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC,ug ml-1,UO_0000274,,4.0
16205,,,18740239,[],CHEMBL4262103,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4261494,Medchemcomm,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
16206,,,18740256,[],CHEMBL4262104,Antibacterial activity against Proteus vulgaris ATCC 13315 after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4261494,Medchemcomm,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,8.0
16207,,,18740273,[],CHEMBL4262105,Antibacterial activity against Bacillus typhi after 24 hrs by two-fold serial dilution based spectrophotometric analysis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4261494,Medchemcomm,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3113446,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,4.0
16208,,Not Active,18740310,[],CHEMBL4262118,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 after 5 passages,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4261494,Medchemcomm,2017.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3113446,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16209,,,18788050,[],CHEMBL4272164,Antibacterial activity against Staphylococcus aureus after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4270534,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16210,,,18788062,[],CHEMBL4272165,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4270534,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16211,,,18788074,[],CHEMBL4272166,Antibacterial activity against Enterococcus faecalis after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4270534,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
16212,,,18788086,[],CHEMBL4272167,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4270534,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16213,,,18788098,[],CHEMBL4272168,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4270534,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16214,,,18788110,[],CHEMBL4272169,Antibacterial activity against Klebsiella pneumoniae after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4270534,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16215,,,18788122,[],CHEMBL4272170,Antibacterial activity against Escherichia coli after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4270534,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
16216,,,18788134,[],CHEMBL4272171,Antibacterial activity against Acinetobacter baumannii after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4270534,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
16217,,,18788146,[],CHEMBL4272172,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4270534,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16218,,,18788158,[],CHEMBL4272173,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4270534,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
16219,,,18788170,[],CHEMBL4272174,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by micro broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4270534,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3122183,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16220,,,18827726,[],CHEMBL4303819,Inhibition of cell viability relative to arbidol control (inhibition index > 1 indicates higher activity) measured by fluorescence (OD590nm) in Vero E6 cells infected with SARS-CoV-2 (strain BavPat1) at MOI 0.002 after 72hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4303097,,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3134268,=,52,0,=,,Inhibition index,,,0.07412,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition index,,,,0.074115044
16221,,,18829048,[],CHEMBL4303805,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4303101,,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3135546,=,52,1,=,,Inhibition,%,,6.88,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Inhibition,%,UO_0000187,,6.88
16222,,,18835025,[],CHEMBL4303810,Antiviral activity against SARS-CoV-2 (USA-WA1/2020 strain) measured by imaging in HRCE cells at MOI 0.4 after 96 hrs (reported as hit score from 0-1 for on-disease vs off-disease activity: scores >0.6 considered hits),F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4303122,,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3141295,=,52,0,=,,Hit score,,,0.1871,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,Hit score,,,,0.187095936
16223,,,18853877,[],CHEMBL4306905,Antibacterial activity against Staphylococcus aureus ATCC 6538 after 18 hrs by two fold serial dilution,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147014,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,1.0,0.13
16224,,,18853878,[],CHEMBL4306909,Antibacterial activity against Bacillus subtilis PTCC 1023 after 18 hrs by two fold serial dilution,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147014,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,1.0,0.13
16225,,,18853879,[],CHEMBL4306910,Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 18 hrs by two fold serial dilution,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147014,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,1.0,0.13
16226,,,18853880,[],CHEMBL4306911,Antibacterial activity against Escherichia coli ATCC 8739 after 18 hrs by two fold serial dilution,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147014,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,1.0,0.13
16227,,,18853881,[],CHEMBL4306913,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 18 hrs by two fold serial dilution,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3147014,=,1,1,=,,MIC,ug.mL-1,,0.13,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,1.0,0.13
16228,,,18853882,[],CHEMBL4306931,Antibacterial activity against Escherichia coli infected in mouse,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3147014,=,1,1,=,,ED50,mg.kg-1,,5.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,5.6
16229,,,18853883,[],CHEMBL4306949,Antibacterial activity against Enterococcus faecalis after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,,MIC,nM,,13000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,1603.0,13.0
16230,,,18853884,[],CHEMBL4306950,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,,MIC,nM,,13000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,1603.0,13.0
16231,,,18853885,[],CHEMBL4306951,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,,MIC,nM,,13000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,1603.0,13.0
16232,,,18853886,[],CHEMBL4306952,Antibacterial activity against methicillin-resistant Staphylococcus aureus after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,,MIC,nM,,13000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,1603.0,13.0
16233,,,18853887,[],CHEMBL4306953,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,,MIC,nM,,13000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,1603.0,13.0
16234,,,18853888,[],CHEMBL4306954,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,,MIC,nM,,13000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,1603.0,13.0
16235,,,18853889,[],CHEMBL4306955,Antibacterial activity against Acinetobacter baumannii after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,,MIC,nM,,13000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,1603.0,13.0
16236,,,18853890,[],CHEMBL4306956,Antibacterial activity against Escherichia coli after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,,MIC,nM,,13000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,1603.0,13.0
16237,,,18853891,[],CHEMBL4306957,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,,MIC,nM,,13000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,1603.0,13.0
16238,,,18853892,[],CHEMBL4306958,Antibacterial activity against Klebsiella pneumoniae after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,,MIC,nM,,13000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,1603.0,13.0
16239,,,18853893,[],CHEMBL4306959,Antibacterial activity against drug-resistant Escherichia coli after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304773,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3147014,=,1,1,=,,MIC,nM,,100000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,100.0
16240,,,18854901,[],CHEMBL4307308,Permeability of the compound measured after compound dilution in PBS/EtOH buffer (70:30) by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304786,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3147318,=,1,0,=,,permeability,10'-6 cm/s,,0.9,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.9
16241,,,18854944,[],CHEMBL4307309,Permeability of the compound at 25 ug/ml by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4304786,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3147318,=,1,0,=,,permeability,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.1
16242,,,18882731,[],CHEMBL4312434,Antibacterial activity against Staphylococcus aureus 11011 incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,,MIC,nM,,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,2.0
16243,,,18882737,[],CHEMBL4312433,Antibacterial activity against Pseudomonas aeruginosa 25349 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,,MIC,nM,,2000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,2.0
16244,,,18882770,[],CHEMBL4312424,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,,MIC,nM,,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,2.0
16245,,,18882805,[],CHEMBL4312429,Antibacterial activity against Staphylococcus epidermidis ATCC 12228 incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,,MIC,nM,,1000.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,uM,UO_0000065,,1.0
16246,,,18882829,[],CHEMBL4312430,Antibacterial activity against Escherichia coli 20411 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,,MIC,nM,,62.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.0625
16247,,,18882853,[],CHEMBL4312431,Antibacterial activity against Acinetobacter baumannii AB1901 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,>,1,1,>,,MIC,nM,,128000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,128.0
16248,,,18882880,[],CHEMBL4312425,Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,,MIC,nM,,1000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,1.0
16249,,,18882896,[],CHEMBL4312426,Antibacterial activity against Salmonella enterica serovar typhimurium C77-31 incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,,MIC,nM,,250.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,uM,UO_0000065,,0.25
16250,,,18882961,[],CHEMBL4312428,Antibacterial activity against Escherichia coli ATCC 25922 incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,,MIC,nM,,125.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.125
16251,,,18882996,[],CHEMBL4312427,Antibacterial activity against Escherichia coli UB1005 incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,,MIC,nM,,4000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,4.0
16252,,,18883048,[],CHEMBL4312432,Antibacterial activity against Acinetobacter baumannii AB1902 clinical isolate incubated for 18 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,>,1,1,>,,MIC,nM,,128000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,128.0
16253,,,18883312,[],CHEMBL4312490,Antibacterial activity against ciprofloxacin-resistant Escherichia coli ATCC 25922 incubated for 18 to 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3150910,=,1,1,=,,MIC,nM,,1000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,1.0
16254,,,18883322,[],CHEMBL4312491,"Resistance index, ratio of MIC for antibacterial activity against ciprofloxacin-resistant Escherichia coli to MIC for Escherichia coli ATCC 25922 incubated for 18 to 24 hrs by broth microdilution method",F,,,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311942,J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3150910,=,1,0,=,,Ratio,,,4.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,4.0
16255,,,18891231,[],CHEMBL4314243,Permeability of the compound in pH 7.4 PBS/EtOH at 25 ug/ml after 18 hrs by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311983,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3151926,=,1,0,=,,permeability,10'-6 cm/s,,0.42,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.42
16256,,,18891259,[],CHEMBL4314272,Permeability of compound by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4311983,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3151926,=,1,0,=,,permeability,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.1
16257,,,18911675,[],CHEMBL4321117,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154624,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16258,,,18911707,[],CHEMBL4321118,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154624,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16259,,,18911739,[],CHEMBL4321119,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154624,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
16260,,,18911771,[],CHEMBL4321120,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by microtiter ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4316612,Bioorg Med Chem Lett,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3154624,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
16261,,,18934627,[],CHEMBL4326746,Antibacterial activity against glycopeptide-intermediate Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4325848,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158827,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16262,,,18934630,[],CHEMBL4326745,Antibacterial activity against Staphylococcus aureus 1199B,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4325848,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158827,>=,1,1,>=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,16.0,0.125
16263,,,18934633,[],CHEMBL4326744,Antibacterial activity against Staphylococcus aureus 1199-3,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4325848,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158827,>=,1,1,>=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,16.0,0.125
16264,,,18934636,[],CHEMBL4326743,Antibacterial activity against Staphylococcus aureus 1199,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4325848,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3158827,>=,1,1,>=,,MIC,ug.mL-1,,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,16.0,0.125
16265,,,18962782,[],CHEMBL4334803,Antibacterial activity against Staphylococcus aureus FDA 209P at sub-MIC by resistant development assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4334431,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3163885,=,1,1,=,,MIC,nM,,800.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,3.0,0.8
16266,,,18962783,[],CHEMBL4334802,Antimicrobial activity against carbapenem-resistant Escherichia coli K12 W3110 at sub-MIC treated by resistant development assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4334431,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3163885,=,1,1,=,,MIC,nM,,200.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,6.0,0.2
16267,,,19001128,[],CHEMBL4343521,Antibacterial activity against methicillin resistant Staphylococcus aureus N315 after 24 hrs by two-fold broth serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,16.0,1.0
16268,,,19001129,[],CHEMBL4343522,Antibacterial activity against Bacillus subtilis ATCC 21216 after 24 hrs by two-fold broth serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,16.0,1.0
16269,,,19001130,[],CHEMBL4343523,Antibacterial activity against Micrococcus luteus ATCC 4698 after 24 hrs by two-fold broth serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,16.0,1.0
16270,,,19001131,[],CHEMBL4343524,Antimicrobial activity against Escherichia coli JM 109 after 24 hrs by two-fold broth serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,16.0,1.0
16271,,,19001132,[],CHEMBL4343525,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by two-fold broth serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,16.0,1.0
16272,,,19001133,[],CHEMBL4343526,Antimicrobial activity against Shigella dysenteriae after 24 hrs by two-fold broth serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL612619,Shigella dysenteriae,Shigella dysenteriae,622.0,,,MIC,ug ml-1,UO_0000274,16.0,1.0
16273,,,19001134,[],CHEMBL4343527,Antifungal activity against Candida albicans ATCC 76615 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,16.0,1.0
16274,,,19001135,[],CHEMBL4343528,Antifungal activity against Candida utilis after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL612309,Cyberlindnera jadinii,Cyberlindnera jadinii,4903.0,,,MIC,ug ml-1,UO_0000274,16.0,1.0
16275,,,19001136,[],CHEMBL4343529,Antifungal activity against Aspergillus flavus after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,,MIC,ug ml-1,UO_0000274,16.0,1.0
16276,,,19001137,[],CHEMBL4343530,Antifungal activity against Saccharomyces cerevisiae after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC,ug ml-1,UO_0000274,16.0,1.0
16277,,,19001138,[],CHEMBL4343531,Antifungal activity against Candida mycoderma after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4342421,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3170469,>=,1,1,>=,,MIC,ug.mL-1,,1.0,CHEMBL613254,Pichia norvegensis,Pichia norvegensis,4921.0,,,MIC,ug ml-1,UO_0000274,16.0,1.0
16278,,,19027705,[],CHEMBL4348801,Antibacterial activity against Methicillin-resistant Staphylococcus aureus CCARM 3167 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174488,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16279,,,19027735,[],CHEMBL4348802,Antibacterial activity against Methicillin-resistant Staphylococcus aureus CCARM 3506 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174488,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16280,,,19027765,[],CHEMBL4348803,Antibacterial activity against Quinolone-resistant Staphylococcus aureus CCARM 3505 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174488,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
16281,,,19027795,[],CHEMBL4348804,Antibacterial activity against Quinolone-resistant Staphylococcus aureus CCARM 3519 assessed as reduction in bacterial cell growth incubated for 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4346701,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174488,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
16282,,,19030409,[],CHEMBL4349287,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4346715,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,,MIC,ug.mL-1,,14.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,14.1
16283,,,19030467,[],CHEMBL4349291,Antifungal activity against Candida albicans,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4346715,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,,MIC,ug.mL-1,,7.8,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,ug ml-1,UO_0000274,,7.8
16284,,,19030484,[],CHEMBL4349293,Antifungal activity against Aspergillus niger,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4346715,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,,MIC,ug.mL-1,,10.2,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,,MIC,ug ml-1,UO_0000274,,10.2
16285,,,19030726,[],CHEMBL4349315,Antibacterial activity against methicillin-resistant Staphylococcus aureus incubated for 18 hrs post 30 mins pre-diffusion by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4346715,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,,MIC,ug.mL-1,,31.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,1000.0,31.0
16286,,,19030735,[],CHEMBL4349316,Antibacterial activity against Bacillus anthracis incubated for 18 hrs post 30 mins pre-diffusion by disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4346715,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,,MIC,ug.mL-1,,31.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,,MIC,ug ml-1,UO_0000274,1000.0,31.0
16287,,,19030738,[],CHEMBL4349317,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4346715,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3174852,=,1,1,=,,MIC,ug.mL-1,,11.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,11.7
16288,,,19047780,[],CHEMBL4354114,Antibacterial activity against methicillin resistant Staphylococcus aureus N315 assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,,MIC,nM,,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.025
16289,,,19047798,[],CHEMBL4354115,Antibacterial activity against Enterococcus faecalis assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,,MIC,nM,,13000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mM,UO_0000065,,0.013
16290,,,19047816,[],CHEMBL4354116,Antibacterial activity against Staphylococcus aureus assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,,MIC,nM,,6000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.006
16291,,,19047834,[],CHEMBL4354117,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,,MIC,nM,,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.003
16292,,,19047852,[],CHEMBL4354118,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,,MIC,nM,,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.003
16293,,,19047870,[],CHEMBL4354119,Antibacterial activity against Klebsiella pneumoniae assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,,MIC,nM,,13000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mM,UO_0000065,,0.013
16294,,,19047888,[],CHEMBL4354120,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,,MIC,nM,,50000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.05
16295,,,19047906,[],CHEMBL4354121,Antibacterial activity against Escherichia coli assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,,MIC,nM,,25000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.025
16296,,,19047924,[],CHEMBL4354122,Antibacterial activity against Pseudomonas aeruginosa assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,,MIC,nM,,6000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.006
16297,,,19047942,[],CHEMBL4354123,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,,MIC,nM,,2000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.002
16298,,,19047960,[],CHEMBL4354124,Antibacterial activity against Acinetobacter baumannii assessed as reduction in bacterial cell viability incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3177663,=,1,1,=,,MIC,nM,,25000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mM,UO_0000065,,0.025
16299,,,19048055,[],CHEMBL4354132,Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as fold change after 16 serial passages at 0.5 times of MIC incubated for 12 hrs by sequential passaging method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351006,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3177663,=,1,0,=,,FC,,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,16.0
16300,,,19050416,[],CHEMBL4354624,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351025,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16301,,,19050436,[],CHEMBL4354625,Antibacterial activity against Enterococcus faecalis incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351025,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
16302,,,19050456,[],CHEMBL4354626,Antibacterial activity against Staphylococcus aureus ATCC 29213 incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351025,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16303,,,19050476,[],CHEMBL4354627,Antibacterial activity against Klebsiella pneumoniae incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351025,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16304,,,19050496,[],CHEMBL4354628,Antibacterial activity against Escherichia coli incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351025,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
16305,,,19050516,[],CHEMBL4354629,Antibacterial activity against Pseudomonas aeruginosa incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351025,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16306,,,19050536,[],CHEMBL4354630,Antibacterial activity against Acinetobacter baumannii incubated for 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351025,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178146,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
16307,,Active,19050571,[],CHEMBL4354655,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 at 0.5 times MIC measured after 6 to 16 passages,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351025,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3178146,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16308,,,19051405,[],CHEMBL4354765,Permeability of the compound at 100 ug/ml measured after compound dilution in PBS/EtOH buffer (70:30) by PAMPA-BBB assay,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351031,Bioorg Med Chem Lett,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3178318,=,1,0,=,,Peff,10'-6 cm/s,,0.42,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.42
16309,,,19051406,[],CHEMBL4354771,Permeability of the compound at 25 ug/ml by PAMPA-BBB assay,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4351031,Bioorg Med Chem Lett,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3178318,=,1,0,=,,Peff,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.1
16310,,,19051580,[],CHEMBL4354972,Antibacterial activity against Pseudomonas aeruginosa by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC90,mg/L,UO_0000274,,2.0
16311,,,19051594,[],CHEMBL4354971,Antibacterial activity against Escherichia coli by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC90,mg/L,UO_0000274,,0.12
16312,,,19051616,[],CHEMBL4354973,Antibacterial activity against Klebsiella by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612535,Klebsiella,Klebsiella,570.0,,,MIC90,mg/L,UO_0000274,,0.5
16313,,,19051630,[],CHEMBL4354974,Antibacterial activity against Bacteroides fragilis by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,>,1,1,>,,MIC90,ug.mL-1,,64.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,,MIC90,mg/L,UO_0000274,,64.0
16314,,,19051644,[],CHEMBL4354975,Antibacterial activity against Haemophilus influenzae with horse blood by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,mg/L,UO_0000274,,0.06
16315,,,19051658,[],CHEMBL4354976,Antibacterial activity against Staphylococcus aureus by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,,MIC90,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC90,mg/L,UO_0000274,,1.0
16316,,,19051672,[],CHEMBL4354977,Antibacterial activity against Streptococcus pneumoniae by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,mg/L,UO_0000274,,16.0
16317,,,19051686,[],CHEMBL4354978,Antibacterial activity against Streptococcus pyogenes by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,mg/L,UO_0000274,,4.0
16318,,,19051700,[],CHEMBL4354979,Antibacterial activity against Enterococcus by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3178412,=,1,1,=,,MIC90,ug.mL-1,,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC90,mg/L,UO_0000274,,4.0
16319,,Not Determined,19051714,[],CHEMBL4354980,Antibacterial activity against Clostridium perfringens by agar diffusion method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3178412,,1,0,,,MIC90,,,,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,,MIC90,,,,
16320,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,19051724,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'g', 'standard_value': '0.4', 'text_value': None, 'type': 'DOSE', 'units': 'g', 'value': '0.4'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL4354987,"Cmax in human at 0.4 g, po bid",A,,,BAO_0002119,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3178412,=,1,1,=,,Cmax,nM,,4697.19,CHEMBL612558,,ADMET,,,,Cmax,mg/L,UO_0000065,,1.5
16321,,,19051726,[],CHEMBL4354988,"AUC in human at 0.4 g, po bid",A,,,BAO_0002120,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3178412,=,1,1,=,,AUC,ng.hr.mL-1,,10000.0,CHEMBL612558,,ADMET,,,,AUC,mg.hr/L,,,10.0
16322,,,19051728,[],CHEMBL4354989,"Half life in human at 0.4 g, po bid",A,,,BAO_0002115,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Hour,3178412,=,1,1,=,,T1/2,hr,,3.0,CHEMBL612558,,ADMET,,,,t1/2,hr,UO_0000032,,3.0
16323,,,19051730,[],CHEMBL4354990,"Protein binding in human at 0.4 g, po bid",A,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4354782,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3178412,=,1,1,=,,PPB,%,,15.0,CHEMBL612558,,ADMET,,,,PB,%,UO_0000187,,15.0
16324,,,19071416,[],CHEMBL4361780,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359852,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16325,,,19071451,[],CHEMBL4361781,Antibacterial activity against methicillin resistant Staphylococcus aureus N 315 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359852,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16326,,,19071486,[],CHEMBL4361782,Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359852,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
16327,,,19071521,[],CHEMBL4361783,Antibacterial activity against Bacillus proteus ATCC 8427 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359852,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,2.0
16328,,,19071556,[],CHEMBL4361784,Antibacterial activity against Escherichia coli JM109 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359852,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16329,,,19071591,[],CHEMBL4361774,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 assessed as reduction in bacterial cell growth incubated for overnight by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359852,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3181905,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
16330,,Not Determined,19073451,[],CHEMBL4362173,Antibacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 incubated for 7 days by resazurin dye based fluorimetric assay,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359864,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3182227,,1,0,,,IC50,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,IC50,,,,
16331,,Not Determined,19073461,[],CHEMBL4362172,Antibacterial activity against Streptococcus pneumoniae ATCC BAA-334 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359864,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3182227,,1,0,,,IC50,,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,IC50,,,,
16332,,Not Determined,19073473,[],CHEMBL4362171,Antibacterial activity against Staphylococcus aureus ATCC 6538 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359864,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3182227,,1,0,,,IC50,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IC50,,,,
16333,,,19073479,[],CHEMBL4362167,Antibacterial activity against Escherichia coli ATCC 8739 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359864,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3182227,>,1,1,>,,IC50,nM,,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IC50,uM,UO_0000065,,0.25
16334,,,19073490,[],CHEMBL4362168,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359864,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3182227,>,1,1,>,,IC50,nM,,500.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IC50,uM,UO_0000065,,0.5
16335,,Not Determined,19073501,[],CHEMBL4362169,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359864,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3182227,,1,0,,,IC50,,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,IC50,,,,
16336,,Not Determined,19073512,[],CHEMBL4362170,Antibacterial activity against Enterococcus faecium ATCC 19434 incubated for 24 hrs by resazurin dye based fluorimetric assay,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4359864,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3182227,,1,0,,,IC50,,,,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,IC50,,,,
16337,,,19092338,[],CHEMBL4366760,Effective permeability of the compound at 25 ug/ml incubated for 18 hrs by PAMPA-BBB assay,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4364279,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3185095,=,1,0,=,,Peff,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.1
16338,,,19092512,[],CHEMBL4366750,Permeability of the compound in pH 7.4 PBS/EtOH at 100 ug/ml by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4364279,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3185095,=,1,0,=,,permeability,10'-6 cm/s,,0.423,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.423
16339,,,19098084,[],CHEMBL4367939,Permeability of compound at 100 ug/ml measured after dilution with PBS/EtOH (70:30) at pH 7.4 after 18 hrs by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4364308,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3185980,=,1,0,=,,permeability,10'-6 cm/s,,0.423,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.423
16340,,,19103093,[],CHEMBL4369116,Permeability of the compound by PAMPA,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4368858,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3187224,=,1,0,=,,permeability,10'-6 cm/s,,0.95,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.95
16341,,,19106299,[],CHEMBL4369603,Antimicrobial activity against Staphylococcus aureus 209p measured every 24 hrs for 5 days by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4368886,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,,MIC,nM,,7500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,7.5
16342,,,19106324,[],CHEMBL4369604,Antimicrobial activity against Bacillus cereus ATCC 8035 measured every 24 hrs for 5 days by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4368886,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,,MIC,nM,,25000.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,uM,UO_0000065,,25.0
16343,,,19106349,[],CHEMBL4369605,Antimicrobial activity against Escherichia coli CDC F-50 measured every 24 hrs for 5 days by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4368886,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,,MIC,nM,,4700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,4.7
16344,,,19106374,[],CHEMBL4369606,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 measured every 24 hrs for 5 days by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4368886,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,,MIC,nM,,9400.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,9.4
16345,,,19106469,[],CHEMBL4369610,Bactericidal activity against Staphylococcus aureus 209p measured after 4 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4368886,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,,MIC,nM,,7500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,7.5
16346,,,19106493,[],CHEMBL4369611,Bactericidal activity against Bacillus cereus ATCC 8035 measured after 4 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4368886,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,,MIC,nM,,50000.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,uM,UO_0000065,,50.0
16347,,,19106517,[],CHEMBL4369612,Bactericidal activity against Escherichia coli CDC F-50 measured after 4 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4368886,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,,MIC,nM,,4700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,4.7
16348,,,19106541,[],CHEMBL4369613,Bactericidal activity against Pseudomonas aeruginosa ATCC 9027 measured after 4 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4368886,Medchemcomm,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3187884,=,1,1,=,,MIC,nM,,48800.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,48.8
16349,,,19130479,[],CHEMBL4374828,Effective permeability of compound by PAMPA,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4373684,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3192831,=,1,0,=,,Peff,10'-6 cm/s,,0.9,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.9
16350,,,19130491,[],CHEMBL4374829,Effective permeability of compound incubated for 8 hrs by PAMPA,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4373684,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3192831,=,1,0,=,,Peff,10'-6 cm/s,,0.46,CHEMBL2362975,,No relevant target,,,,Peff,10'-6 cm/s,,,0.46
16351,,,19130503,[],CHEMBL4374830,Fraction absorbed of the compound by PAMPA,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4373684,Medchemcomm,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3192831,=,1,0,=,,Fa,%,,23.51,CHEMBL2362975,,No relevant target,,,,Fa,%,UO_0000187,,23.51
16352,,,19164364,[],CHEMBL4384013,Antibacterial activity against Proteus vulgaris after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382229,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198398,=,1,1,=,,MIC,ug.mL-1,,62.5,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,62.5
16353,,,19164476,[],CHEMBL4384033,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as zone of inhibition at 25 ug/ml by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382229,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3198398,=,1,1,=,,IZ,mm,,19.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,25.0,19.0
16354,,,19164479,[],CHEMBL4384034,Antibacterial activity against Streptococcus pyogenes MTCC 442 assessed as zone of inhibition at 25 ug/ml by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382229,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3198398,=,1,1,=,,IZ,mm,,19.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,IZ,mm,UO_0000016,25.0,19.0
16355,,,19164482,[],CHEMBL4384035,Antibacterial activity against Escherichia coli MTCC 443 assessed as zone of inhibition at 25 ug/ml by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382229,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3198398,=,1,1,=,,IZ,mm,,19.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,25.0,19.0
16356,,,19164485,[],CHEMBL4384036,Antibacterial activity against Pseudomonas aeruginosa MTCC 424 assessed as zone of inhibition at 25 ug/ml by agar well diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382229,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3198398,=,1,1,=,,IZ,mm,,19.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,25.0,19.0
16357,,,19165347,[],CHEMBL4384114,Antibacterial activity against methicillin-resistant Staphylococcus aureus after overnight incubation by micro broth dilution analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382233,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198680,=,1,0,=,,MIC99,ug ml-1,,0.61,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC99,ug ml-1,UO_0000274,,0.61
16358,,,19165432,[],CHEMBL4384115,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis after overnight incubation by micro broth dilution analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382233,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198680,=,1,0,=,,MIC99,ug ml-1,,0.73,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC99,ug ml-1,UO_0000274,,0.73
16359,,,19165517,[],CHEMBL4384116,Antibacterial activity against methicillin-resistant Staphylococcus haemolyticus after overnight incubation by micro broth dilution analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382233,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3198680,=,1,0,=,,MIC99,ug ml-1,,0.58,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC99,ug ml-1,UO_0000274,,0.58
16360,,,19166004,[],CHEMBL4384132,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as zone of inhibition at 30 ug/mL after 24 hrs by agar disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382233,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3198680,=,1,1,=,,IZ,mm,,10.04,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,10.04
16361,,,19166006,[],CHEMBL4384133,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as zone of inhibition at 30 ug/mL after 24 hrs by agar disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382233,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3198680,=,1,1,=,,IZ,mm,,9.07,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,IZ,mm,UO_0000016,,9.07
16362,,,19166008,[],CHEMBL4384134,Antibacterial activity against methicillin-resistant Staphylococcus haemolyticus assessed as zone of inhibition at 30 ug/mL after 24 hrs by agar disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382233,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3198680,=,1,1,=,,IZ,mm,,12.71,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,IZ,mm,UO_0000016,,12.71
16363,,Active,19166047,[],CHEMBL4384137,Antibiofilm activity against methicillin-resistant Staphylococcus aureus at 2 times MIC after 24 hrs by crystal violet staining-based UV-visible spectrophotometric analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382233,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3198680,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16364,,,19166066,[],CHEMBL4384139,Antibiofilm activity against methicillin-resistant Staphylococcus aureus planktonic biofilm assessed as optical density at 492 nm at MIC after 24 hrs by crystal violet staining-based UV-visible spectrophotometric analysis,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382233,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3198680,=,1,0,=,,OD,,,0.695,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,OD,,,,0.695
16365,,,19166144,[],CHEMBL4384155,Antibacterial activity against Escherichia coli NCTC 10418 infected in po dosed CF mouse measured after 1 week,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382234,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3198685,=,1,1,=,,ED50,mg.kg-1,,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,6.0
16366,,,19166149,[],CHEMBL4384157,Toxicity in po dosed CF mouse measured after 1 week,T,,,BAO_0002117,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382234,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3198685,=,1,1,=,,LD50,mg.kg-1,,4000.0,CHEMBL612558,,ADMET,,,,LD50,mg kg-1,UO_0000308,,4000.0
16367,,,19167763,[],CHEMBL4384312,Effective permeability of the compound in PBS/EtOH at 100 ug/ml after 18 hrs by PAMPA,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382240,Bioorg Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3198985,=,1,0,=,,Peff,ucm/s,,0.42,CHEMBL2362975,,No relevant target,,,,Peff,ucm/s,,,0.42
16368,,,19167774,[],CHEMBL4384313,Effective permeability of the compound by PAMPA,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4382240,Bioorg Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3198985,=,1,0,=,,Peff,ucm/s,,0.1,CHEMBL2362975,,No relevant target,,,,Peff,ucm/s,,,0.1
16369,,,19216789,[],CHEMBL4394044,Permeability of compound at pH 7.4 by PAMPA,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4393658,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3207704,=,1,0,=,,permeability,10'-6 cm/s,,0.54,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.54
16370,,,19237658,[],CHEMBL4399096,"Lipophilicity, log k of the compound at 100 ug/ml by micellar electrokinetic chromatography",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3211462,=,1,0,=,,log K,,,0.1033,CHEMBL2362975,,No relevant target,,,,log K,,,,0.1033
16371,,,19237681,[],CHEMBL4399097,Antibacterial activity against Staphylococcus aureus ATCC 6538 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
16372,,,19237704,[],CHEMBL4399098,Bactericidal activity against Staphylococcus aureus ATCC 6538 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,0.25
16373,,,19237728,[],CHEMBL4399099,Antibacterial activity against methicillin resistant Staphylococcus aureus N315 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16374,,,19237751,[],CHEMBL4399100,Bactericidal activity against methicillin resistant Staphylococcus aureus N315 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.0
16375,,,19237775,[],CHEMBL4399101,Antibacterial activity against Staphylococcus epidermidis ATCC 14990 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.5
16376,,,19237798,[],CHEMBL4399102,Bactericidal activity against Staphylococcus epidermidis ATCC 14990 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,,MBC,ug ml-1,,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC,ug ml-1,UO_0000274,,2.0
16377,,,19237822,[],CHEMBL4399103,Antibacterial activity against Enterococcus hirae ATCC 1052 cultured in BHI medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,,MIC,ug ml-1,UO_0000274,,64.0
16378,,,19237841,[],CHEMBL4399104,Bactericidal activity against Enterococcus hirae ATCC 1052 cultured in BHI medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,,MBC,ug ml-1,,64.0,CHEMBL614623,Enterococcus hirae,Enterococcus hirae,1354.0,,,MBC,ug ml-1,UO_0000274,,64.0
16379,,,19237857,[],CHEMBL4399105,Antibacterial activity against Bacillus subtilis ATCC 6633 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,,MIC,ug ml-1,UO_0000274,,0.125
16380,,,19237880,[],CHEMBL4399106,Bactericidal activity against Bacillus subtilis ATCC 6633 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL613907,Bacillus spizizenii,Bacillus spizizenii,96241.0,,,MBC,ug ml-1,UO_0000274,,0.125
16381,,,19237904,[],CHEMBL4399107,Antibacterial activity against Escherichia coli ATCC 8739 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.032
16382,,,19237927,[],CHEMBL4399108,Bactericidal activity against Escherichia coli ATCC 8739 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,,MBC,ug ml-1,,0.063,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,0.063
16383,,,19237951,[],CHEMBL4399109,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.25
16384,,,19237974,[],CHEMBL4399110,Bactericidal activity against Pseudomonas aeruginosa ATCC 9027 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,0.25
16385,,,19237998,[],CHEMBL4399111,Antibacterial activity against Proteus vulgaris NCTC 4635 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,0.016,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.016
16386,,,19238022,[],CHEMBL4399112,Bactericidal activity against Proteus vulgaris NCTC 4635 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,,MBC,ug ml-1,,0.016,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MBC,ug ml-1,UO_0000274,,0.016
16387,,,19238046,[],CHEMBL4399113,Antibacterial activity against methicillin resistant Staphylococcus aureus 6347 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16388,,,19238069,[],CHEMBL4399114,Bactericidal activity against methicillin resistant Staphylococcus aureus 6347 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,,MBC,ug ml-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.0
16389,,,19238093,[],CHEMBL4399115,Antibacterial activity against methicillin resistant Staphylococcus epidermidis ATCC 13199 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
16390,,,19238116,[],CHEMBL4399116,Bactericidal activity against methicillin resistant Staphylococcus epidermidis ATCC 13199 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,,MBC,ug ml-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MBC,ug ml-1,UO_0000274,,0.125
16391,,,19238140,[],CHEMBL4399117,Antibacterial activity against Streptococcus pneumoniae cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
16392,,,19238158,[],CHEMBL4399118,Bactericidal activity against Streptococcus pneumoniae cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,>,1,0,>,,MBC,ug ml-1,,512.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MBC,ug ml-1,UO_0000274,,512.0
16393,,,19238178,[],CHEMBL4399119,Antibacterial activity against Serratia marcescens ATCC 12795 cultured in MH medium assessed as reduction in bacterial growth incubated for 48 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,0.25
16394,,,19238201,[],CHEMBL4399120,Bactericidal activity against Serratia marcescens ATCC 12795 cultured in MH medium assessed as reduction in bacterial survival incubated for 48 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4396913,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3211462,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MBC,ug ml-1,UO_0000274,,0.25
16395,,,19247100,[],CHEMBL4400925,Antibacterial activity against Streptococcus pyogenes CMCC 32067 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,>,1,1,>,,MIC,nM,,401250.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,umol/L,UO_0000065,,401.25
16396,,,19247141,[],CHEMBL4400924,Antibacterial activity against Staphylococcus aureus CMCC 25923 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,390.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/L,UO_0000065,,0.39
16397,,,19247182,[],CHEMBL4400923,Antibacterial activity against Staphylococcus aureus CMCC(B) 26003 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,390.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/L,UO_0000065,,0.39
16398,,,19247229,[],CHEMBL4400928,Antibacterial activity against Bacillus subtilis CMCC 63501 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,6270.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,umol/L,UO_0000065,,6.27
16399,,,19247269,[],CHEMBL4400927,Antibacterial activity against Enterococcus faecalis CMCC 29212 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,3130.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,umol/L,UO_0000065,,3.13
16400,,,19247310,[],CHEMBL4400926,Antibacterial activity against Streptococcus pneumoniae CMCC 31968 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,>,1,1,>,,MIC,nM,,401250.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,umol/L,UO_0000065,,401.25
16401,,,19247354,[],CHEMBL4400929,Antibacterial activity against Escherichia coli CMCC 25922 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,390.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/L,UO_0000065,,0.39
16402,,,19247395,[],CHEMBL4400930,Antibacterial activity against Escherichia coli CMCC 44568 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,390.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/L,UO_0000065,,0.39
16403,,,19247436,[],CHEMBL4400931,Antibacterial activity against Pseudomonas aeruginosa CMCC 27853 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,6270.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/L,UO_0000065,,6.27
16404,,,19247477,[],CHEMBL4400932,Antibacterial activity against Pseudomonas aeruginosa CMCC 10104 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,12540.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/L,UO_0000065,,12.54
16405,,,19247488,[],CHEMBL4400933,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,1570.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/L,UO_0000065,,1.57
16406,,,19247499,[],CHEMBL4400934,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,780.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,umol/L,UO_0000065,,0.78
16407,,,19247510,[],CHEMBL4400935,Antibacterial activity against multidrug-resistant Escherichia coli ATCC BAA-196 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,1570.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,umol/L,UO_0000065,,1.57
16408,,,19247521,[],CHEMBL4400936,Antibacterial activity against multidrug-resistant Pseudomonas aeruginosa ATCC BAA-2111 measured after 24 hrs by ELISA,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3213108,=,1,1,=,,MIC,nM,,3130.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,umol/L,UO_0000065,,3.13
16409,,,19247525,[],CHEMBL4400937,Antibacterial activity against Staphylococcus aureus CMCC 25923 assessed as ratio of MIC after and before 16 passages at sub-MIC,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3213108,=,1,0,=,,Ratio,,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,32.0
16410,,,19247527,[],CHEMBL4400938,Antibacterial activity against Escherichia coli CMCC 44568 assessed as ratio of MIC after and before 16 passages at sub-MIC,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4400518,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3213108,=,1,0,=,,Ratio,,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,16.0
16411,,,19371317,[],CHEMBL4424945,Permeability of the compound in pH 7.4 PBS/EtOH at 100 ug/ml after 18 hrs by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4422689,Bioorg Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3242250,=,1,0,=,,permeability,10'-6 cm/s,,0.42,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.42
16412,,,19371328,[],CHEMBL4424946,Permeability of the compound in pH 7.4 PBS at 200 uL after 18 hrs by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4422689,Bioorg Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3242250,=,1,0,=,,permeability,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,,0.1
16413,,,19428180,[],CHEMBL4428439,Antimicrobial activity against Eberthella typhosa ATCC 14028 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,4.0
16414,,,19428194,[],CHEMBL4428440,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16415,,,19428208,[],CHEMBL4428442,Antimicrobial activity against Bacillus proteus ATCC13315 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL4296593,Proteus hauseri,Proteus hauseri,183417.0,,,MIC,ug ml-1,UO_0000274,,4.0
16416,,,19428222,[],CHEMBL4428441,Antimicrobial activity against Escherichia coli JM109 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
16417,,,19428236,[],CHEMBL4428443,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16418,,,19428250,[],CHEMBL4428444,Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16419,,,19428264,[],CHEMBL4428445,Antimicrobial activity against Bacillus subtilis ATCC 6633 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,1.0
16420,,,19428278,[],CHEMBL4428446,Antimicrobial activity against Micrococcus luteus ATCC 4698 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3245236,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614421,Micrococcus luteus,Micrococcus luteus,1270.0,,,MIC,ug ml-1,UO_0000274,,2.0
16421,,Not Determined,19428292,[],CHEMBL4428447,Antimicrobial activity against Candida utilis ATCC 9950 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3245236,,1,0,,,MIC80,,,,CHEMBL612309,Cyberlindnera jadinii,Cyberlindnera jadinii,4903.0,,,MIC80,,,,
16422,,Not Determined,19428306,[],CHEMBL4428448,Antimicrobial activity against Aspergillus flavus ATCC 204304 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3245236,,1,0,,,MIC80,,,,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,,MIC80,,,,
16423,,Not Determined,19428320,[],CHEMBL4428449,Antimicrobial activity against beer yeast ATCC 9763 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3245236,,1,0,,,MIC80,,,,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,,MIC80,,,,
16424,,Not Determined,19428334,[],CHEMBL4428450,Antimicrobial activity against Candida albicans ATCC 76615 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3245236,,1,0,,,MIC80,,,,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC80,,,,
16425,,Not Determined,19428348,[],CHEMBL4428451,Antimicrobial activity against Candida mycoderma ATCC 9888 incubated for 24 hrs by NCCLS protocol based method,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428036,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3245236,,1,0,,,MIC80,,,,CHEMBL612545,,Unchecked,,,,MIC80,,,,
16426,,,19436727,[],CHEMBL4430638,Antibacterial activity against multidrug resistant Escherichia coli 1137 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428104,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3246700,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.25
16427,,,19436728,[],CHEMBL4430637,Antibacterial activity against methicillin resistant Staphylococcus aureus 3089 after 24 hrs by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4428104,Bioorg Med Chem Lett,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3246700,>,1,1,>,,MIC,ug.mL-1,,40.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,40.0
16428,,,19472528,[],CHEMBL4478911,Permeability of the compound at pH 7.4 after 18 hrs by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4477223,Bioorg Med Chem,2016.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3256084,=,1,0,=,,permeability,10'-6 cm/s,,0.1,CHEMBL2362975,,No relevant target,,,,permeability,10'-6 cm/s,,0.9,0.1
16429,,,19486628,[],CHEMBL4481665,Antimicrobial activity against penicillin-resistant Staphylococcus aureus ATCC 29213 assessed as ratio of MIC after and before 15 serial passages preincubated followed by replating and measured after 24 hrs,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4480418,Bioorg Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3258825,=,1,0,=,,Ratio,,,500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,500.0
16430,,,19956676,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4495564,,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3343094,=,52,1,=,,Inhibition,%,,34.2,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,34.2
16431,,,19960167,[],CHEMBL4495582,SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM  by FRET kind of response from peptide substrate,F,,,BAO_0000201,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4495564,,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3346585,=,52,1,=,,Inhibition,%,,21.69,CHEMBL4523582,Severe acute respiratory syndrome coronavirus 2,Replicase polyprotein 1ab,2697049.0,,,Inhibition,%,UO_0000187,,21.68565005
16432,,,20149329,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4495565,,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3360966,=,52,1,=,,Inhibition,%,,-0.15,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.15
16433,,,20150691,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4495565,,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3364457,=,52,1,=,,Inhibition,%,,-0.08,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.08
16434,,Median N= 2; Maxinhib 4.8 Pct,20166430,[],CHEMBL4296189,"Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4513141,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3370512,>,40,1,>,,MIC,nM,,10000.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,uM,UO_0000065,,10.0
16435,,Median N= 2; Maxinhib 6.5 Pct,20166431,[],CHEMBL4296190,"Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4513141,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3370512,>,40,1,>,,MIC,nM,,10000.0,CHEMBL365,Cryptococcus neoformans,Cryptococcus neoformans,5207.0,,,MIC,uM,UO_0000065,,10.0
16436,,Median N= 2,20166432,[],CHEMBL4296185,"Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4513141,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3370512,=,40,1,=,,MIC,nM,,625.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,0.625
16437,,Median N= 2; Range >10 - 10  Um,20166433,[],CHEMBL4296186,"Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4513141,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3370512,=,40,1,=,,MIC,nM,,10000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,10.0
16438,,Median N= 2; Maxinhib 11.8 Pct,20166434,[],CHEMBL4296187,"Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4513141,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3370512,>,40,1,>,,MIC,nM,,10000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,10.0
16439,,Median N= 2,20166435,[],CHEMBL4296188,"Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4513141,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3370512,=,40,1,=,,MIC,nM,,5000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,uM,UO_0000065,,5.0
16440,,Median N= 2,20166436,[],CHEMBL4296184,"Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600)",F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4513141,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3370512,=,40,1,=,,MIC,nM,,5000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,5.0
16441,,Median N= 2; Maxinhib 33.3 Pct,20166437,[],CHEMBL4296191,"Cytotoxicity against HEK293 cells (CO-ADD:MA_007); CC50 by cell viability assay in DMEM (10% FBS) media using TC plates, by Resazurin F(560/590)",F,,,BAO_0000187,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4513141,,,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3370512,>,40,1,>,,CC50,nM,,10000.0,CHEMBL614818,Homo sapiens,HEK293,9606.0,,,CC50,uM,UO_0000065,,10.0
16442,,,20612327,[],CHEMBL4606424,"Resistance index, ratio of MIC for antibacterial activity against Staphylococcus aureus ATCC 29213 passed over 19 cycles in presence of compound for period of 15 consecutive days by broth microdilution method to MIC for antibacterial activity against Staphylococcus aureus ATCC 29213",F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4602730,J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3467606,=,1,0,=,,Ratio,,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,128.0
16443,,,20640488,[],CHEMBL4612952,Induction of Escherichia coli K12 MG1655 recA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,,,BAO_0000179,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4610120,J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3473710,=,1,0,=,,FC,,,20.0,CHEMBL3434,Escherichia coli K-12,Recombinase A,83333.0,,,FC,,,35.0,20.0
16444,,,20640495,[],CHEMBL4612953,Induction of Escherichia coli K12 MG1655 lexA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,,,BAO_0000179,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4610120,J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3473710,=,1,0,=,,FC,,,5.0,CHEMBL4630871,Escherichia coli,LexA repressor,562.0,,,FC,,,13.0,5.0
16445,,,20640502,[],CHEMBL4612954,Induction of Escherichia coli K12 MG1655 recN promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,,,BAO_0000179,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4610120,J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3473710,=,1,0,=,,FC,,,14.0,CHEMBL4630870,Escherichia coli,DNA repair protein RecN,562.0,,,FC,,,32.0,14.0
16446,,,20640509,[],CHEMBL4612955,Induction of Escherichia coli K12 MG1655 sulA promotor measured at 30 mins interval for 20 hrs by fluorescence assay relative to control,B,,,BAO_0000179,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4610120,J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3473710,=,1,0,=,,FC,,,17.0,CHEMBL1287594,Escherichia coli K-12,Cell division inhibitor sulA,83333.0,,,FC,,,41.0,17.0
16447,,,20642006,[],CHEMBL4613438,In vivo antibacterial activity against Escherichia coli infected in po dosed mouse,F,,,BAO_0003036,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4613208,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3474073,=,1,1,=,,ED50,mg.kg-1,,6.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,ED50,mg kg-1,UO_0000308,,6.0
16448,,,20642007,[],CHEMBL4613440,Toxicity in po dosed mouse,T,,,BAO_0002117,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4613208,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3474073,=,1,1,=,,LD50,mg.kg-1,,4000.0,CHEMBL612558,,ADMET,,,,LD50,mg kg-1,UO_0000308,,4000.0
16449,,,20643584,[],CHEMBL4613463,Cytotoxicity against human MCF7 cells assessed as reduction in cell viability by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4613209,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3474304,=,1,1,=,,IC50,nM,,137000.0,CHEMBL387,Homo sapiens,MCF7,9606.0,,,IC50,uM,UO_0000065,238.0,137.0
16450,,,20643585,[],CHEMBL4613533,Cytotoxicity against human SK-MEL-3 cells assessed as reduction in cell viability by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4613209,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3474304,=,1,1,=,,IC50,nM,,137000.0,CHEMBL614920,Homo sapiens,SK-MEL3,9606.0,,,IC50,uM,UO_0000065,238.0,137.0
16451,,,20643586,[],CHEMBL4613534,Cytotoxicity against human A431 cells assessed as reduction in cell viability by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4613209,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3474304,=,1,1,=,,IC50,nM,,137000.0,CHEMBL614069,Homo sapiens,A-431,9606.0,,,IC50,uM,UO_0000065,238.0,137.0
16452,,,20643587,[],CHEMBL4613535,Cytotoxicity against human EJ cells assessed as reduction in cell viability by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4613209,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3474304,=,1,1,=,,IC50,nM,,137000.0,CHEMBL614292,Homo sapiens,EJ,9606.0,,,IC50,uM,UO_0000065,238.0,137.0
16453,,,20643588,[],CHEMBL4613536,Cytotoxicity against human SW480 cells assessed as reduction in cell viability by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4613209,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3474304,=,1,1,=,,IC50,nM,,137000.0,CHEMBL612544,Homo sapiens,SW480,9606.0,,,IC50,uM,UO_0000065,238.0,137.0
16454,,,20643589,[],CHEMBL4613566,Antiproliferative activity against human A549 cells after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4613209,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3474304,>,1,1,>,,IC50,nM,,302.0,CHEMBL392,Homo sapiens,A549,9606.0,,,IC50,nM,UO_0000065,,302.0
16455,,,20643590,[],CHEMBL4613567,Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4613209,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3474304,>,1,1,>,,IC50,nM,,302.0,CHEMBL383,Homo sapiens,HL-60,9606.0,,,IC50,nM,UO_0000065,,302.0
16456,,,20703239,[],CHEMBL4627783,Antibacterial activity against methicillin-resistant Staphylococcus aureus by two fold serial microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16457,,,20703253,[],CHEMBL4627784,Antibacterial activity against Staphylococcus aureus by two fold serial microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
16458,,,20703267,[],CHEMBL4627785,Antibacterial activity against Staphylococcus aureus ATCC 25923 by two fold serial microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16459,,,20703281,[],CHEMBL4627786,Antibacterial activity against Enterococcus faecalis by two fold serial microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
16460,,,20703295,[],CHEMBL4627787,Antibacterial activity against Klebsiella pneumoniae by two fold serial microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16461,,,20703309,[],CHEMBL4627788,Antibacterial activity against Escherichia coli by two fold serial microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
16462,,,20703323,[],CHEMBL4627789,Antibacterial activity against Escherichia coli ATCC 25922 by two fold serial microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16463,,,20703337,[],CHEMBL4627790,Antibacterial activity against Pseudomonas aeruginosa by two fold serial microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16464,,,20703351,[],CHEMBL4627791,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by two fold serial microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
16465,,,20703365,[],CHEMBL4627792,Antibacterial activity against Acinetobacter baumannii by two fold serial microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
16466,,Not Active,20703371,[],CHEMBL4627799,Antibacterial activity against Enterococcus faecalis measured after 16 passages by microbroth dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3486700,,1,0,,,Activity,,,,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,Activity,,,,
16467,,,20703402,[],CHEMBL4627805,Antibacterial activity against Staphylococcus aureus ATCC 29213 by two fold serial microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4627266,Bioorg Med Chem Lett,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3486700,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16468,,,22072456,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4495565,,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3360966,=,52,1,=,,Inhibition,%,,-0.15,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.15
16469,,,22075947,[],CHEMBL4513082,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4495565,,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3364457,=,52,1,=,,Inhibition,%,,-0.08,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,inhibition,%,UO_0000187,,-0.08
16470,,No. Measurements = 1,22083594,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4651402,,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3491118,>,57,1,>,,IC50,nM,,20000.0,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,IC50,M,UO_0000065,,2e-05
16471,,No. Measurements = 1,22083595,[],CHEMBL4651403,Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4651402,,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3491118,<,57,1,>,,IC50,nM,,19952.62,CHEMBL4303835,Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2,2697049.0,,,pIC50,,UO_0000065,,4.7
16472,,Not Active,22386697,[],CHEMBL4666206,Antibacterial activity against Klebsiella pneumoniae measured every 24 hrs after several passages by serial dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3507134,,1,0,,,Activity,,,,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Activity,,,,
16473,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,22386711,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.5', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '90.0'}]",CHEMBL4666210,Inhibition of Escherichia coli DNA gyrase holoenzyme assessed as reduction in pBR322 DNA supercoiling using pBR322 plasmid DNA as substrate incubated for 90 mins in presence of ATP by ethidium bromide staining based agarose gel electrophoresis analysis,B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,"{'bei': '14.81', 'le': '0.28', 'lle': '3.46', 'sei': '6.34'}",CHEMBL9,NORFLOXACIN,CHEMBL9,4.73,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,IC50,nM,,18600.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,18.6
16474,,,22386742,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4666211,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,MIC,nM,,6000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.006
16475,,,22386928,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4666217,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,MIC,nM,,25000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mM,UO_0000065,,0.025
16476,,,22386959,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4666218,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,MIC,nM,,2000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.002
16477,,,22386990,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4666219,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,MIC,nM,,25000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.025
16478,,,22387021,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4666220,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,MIC,nM,,50000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.05
16479,,,22387053,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4666221,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,MIC,nM,,13000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mM,UO_0000065,,0.013
16480,,,22387085,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4666222,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,MIC,nM,,6000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.006
16481,,,22387116,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4666223,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,MIC,nM,,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.003
16482,,,22387147,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4666224,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,MIC,nM,,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.002
16483,,,22387179,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4666225,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,MIC,nM,,13000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mM,UO_0000065,,0.013
16484,,,22387210,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4666226,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth after 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665627,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3507134,=,1,1,=,,MIC,nM,,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.025
16485,,,22404946,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '100.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.6667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '40.0'}]",CHEMBL4670418,Permeability of the compound at 100 uM measured after 40 mins by PAMPA,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4665789,J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3510209,=,1,0,=,,permeability,10^-6 cm/s,,0.56,CHEMBL612558,,ADMET,,,,permeability,10^-6 cm/s,,,0.56
16486,,,22424805,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL4674722,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4673214,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3514143,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16487,,,22424823,[],CHEMBL4674725,Resistance ratio of compound MIC for Staphylococcus aureus ATCC 29213 after 20 passages to compound MIC for Staphylococcus aureus ATCC 29213 after 16 to 20 hrs by CLSI-based broth microdilution method,F,,,BAO_0000193,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4673214,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3514143,=,1,0,=,,Ratio,,,256.0,CHEMBL612545,,Unchecked,,,,Ratio,,,,256.0
16488,,,22434304,[],CHEMBL4677249,Antibacterial activity against Staphylococcus aureus SA-1199B,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4673276,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3515518,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
16489,,Not Active,22455652,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL4681933,Bactericidal activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial killing by measuring reduction in bacterial colony count at 64 times MIC incubated for 2 hrs by time-kill kinetics method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680106,J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3519433,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16490,,,22455661,[],CHEMBL4681941,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 grown under presence of test compound at 1/2 MIC assessed as inhibition of bacterial growth measured after 14 passages by broth microdilution method relative to wild type,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680106,J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3519433,>,1,0,>,,Ratio,,,80.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,80.0
16491,,,22464189,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '0.5', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '0.5'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4683670,Antibacterial activity against multidrug resistant Staphylococcus aureus ATCC 43300 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3520704,=,1,1,=,,IZ,mm,,25.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,25.0
16492,,,22464199,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '0.5', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '0.5'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4683671,Antibacterial activity against multidrug resistant Staphylococcus aureus ATCC 33591 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3520704,=,1,1,=,,IZ,mm,,26.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,26.0
16493,,,22464209,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '0.5', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '0.5'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4683672,Antibacterial activity against multidrug resistant Escherichia coli ATCC BAA-196 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3520704,=,1,1,=,,IZ,mm,,27.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,27.0
16494,,,22464219,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '0.5', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '0.5'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4683673,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa ATCC BAA-2111 assessed as diameter of inhibition zone at 0.5 mg/ml incubated for 24 hrs by agar diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3520704,=,1,1,=,,IZ,mm,,24.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,DIZ,mm,UO_0000016,,24.0
16495,,,22464229,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '1.0'}]",CHEMBL4683674,Antibacterial activity against multidrug resistant Staphylococcus aureus ATCC 43300 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,1,=,,MIC,ug.mL-1,,1.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.25
16496,,,22464239,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '1.0'}]",CHEMBL4683675,Antibacterial activity against multidrug resistant Staphylococcus aureus ATCC 33591 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
16497,,,22464249,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '1.0'}]",CHEMBL4683676,Antibacterial activity against multidrug resistant Escherichia coli ATCC BAA-196 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,1,=,,MIC,ug.mL-1,,1.57,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.57
16498,,,22464259,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '1.0'}]",CHEMBL4683677,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa ATCC BAA-2111 assessed as reduction in bacterial growth incubated for 1 day by paper disk diffusion method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,1,=,,MIC,ug.mL-1,,3.13,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.13
16499,,,22464269,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4683678,Bactericidal activity against Staphylococcus aureus ATCC 43300 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,0,=,,MBC,ug ml-1,,2.81,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,2.81
16500,,,22464279,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4683679,Bactericidal activity against Staphylococcus aureus ATCC 33591 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,0,=,,MBC,ug ml-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,1.56
16501,,,22464289,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4683680,Bactericidal activity against Escherichia coli ATCC BAA-196 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,0,=,,MBC,ug ml-1,,3.53,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,ug ml-1,UO_0000274,,3.53
16502,,,22464299,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4683681,Bactericidal activity against Pseudomonas aeruginosa ATCC BAA-2111 incubated for 24 hrs followed by transferring to freshly prepared broth medium and measured after 24 hrs by broth microdilution assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4680155,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3520704,=,1,0,=,,MBC,ug ml-1,,4.69,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,ug ml-1,UO_0000274,,4.69
16503,,,22755076,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '1.0'}]",CHEMBL4700631,Antibacterial activity against Bacillus subtilis assessed as inhibition zone at 1 mg/ml measured after overnight incubation by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4699440,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3532120,=,1,1,=,,IZ,mm,,2.5,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,IZ,mm,UO_0000016,,2.5
16504,,,22755090,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '1.0'}]",CHEMBL4700632,Antibacterial activity against Staphylococcus aureus assessed as inhibition zone at 1 mg/ml measured after overnight incubation by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4699440,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3532120,=,1,1,=,,IZ,mm,,2.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,IZ,mm,UO_0000016,,2.5
16505,,,22755104,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '1.0'}]",CHEMBL4700633,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition zone at 1 mg/ml measured after overnight incubation by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4699440,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3532120,=,1,1,=,,IZ,mm,,2.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,IZ,mm,UO_0000016,,2.5
16506,,,22755118,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'mg/ml', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'mg/ml', 'value': '1.0'}]",CHEMBL4700634,Antibacterial activity against Escherichia coli assessed as inhibition zone at 1 mg/ml measured after overnight incubation by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4699440,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3532120,=,1,1,=,,IZ,mm,,2.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,IZ,mm,UO_0000016,,2.5
16507,,,22755975,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4700719,Antibacterial activity against Klebsiella pneumoniae MTCC 618 incubated for 24 hrs by microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4699440,Eur J Med Chem,2019.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3532120,=,1,1,=,,MIC,ug.mL-1,,9.375,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,9.375
16508,,,22760774,[],CHEMBL4702016,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as ratio of MIC after and before 13 serial passages,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4699493,J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3533170,=,1,0,=,,Ratio,,,22.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,22.0
16509,,,22886463,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '240.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '10.0'}]",CHEMBL4728207,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as ratio of MIC after and before 10 serial passages at 0.5 times MIC passaged daily for 10 days,F,,,BAO_0000193,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4725344,J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3552146,=,1,0,=,,Ratio,,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,128.0
16510,,,22903632,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4732609,Antibacterial activity against methicillin resistant Staphylococcus aureus assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732030,RSC Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16511,,,22903650,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4732610,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732030,RSC Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,32.0
16512,,,22903668,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4732611,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732030,RSC Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16513,,,22903686,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4732612,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732030,RSC Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16514,,,22903704,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4732613,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732030,RSC Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16515,,,22903722,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4732614,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732030,RSC Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16516,,,22903740,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4732615,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732030,RSC Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
16517,,,22903758,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4732616,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732030,RSC Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16518,,,22903776,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4732617,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732030,RSC Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
16519,,,22903794,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4732618,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732030,RSC Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16520,,,22903812,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4732619,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth after 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732030,RSC Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3555522,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
16521,,,22922223,[],CHEMBL4736873,Antibacterial activity against Staphylococcus aureus MTCC 96 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558983,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,10.0
16522,,,22922243,[],CHEMBL4736874,Antibacterial activity against Escherichia coli MTCC 443 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558983,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,10.0
16523,,,22922263,[],CHEMBL4736875,Antibacterial activity against Pseudomonas aeruginosa MTCC 1688 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558983,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,10.0
16524,,,22922317,[],CHEMBL4736878,Antibacterial activity against Streptococcus pyogenes MTCC 442 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4732167,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3558983,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,10.0
16525,,,22961617,[],CHEMBL4768925,Antibacterial activity against methicillin-resistant Staphylococcus aureus N. 315,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765291,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16526,,,22961680,[],CHEMBL4768928,Antibacterial activity against Staphylococcus aureus ATCC 25923,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765291,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16527,,,22961701,[],CHEMBL4768929,Antibacterial activity against Bacillus subtilis ATCC 6633,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765291,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,ug ml-1,UO_0000274,,4.0
16528,,,22961722,[],CHEMBL4768930,Antibacterial activity against Campylobacter coli JM 109,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765291,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL3301405,Campylobacter coli,Campylobacter coli,195.0,,,MIC,ug ml-1,UO_0000274,,8.0
16529,,,22961743,[],CHEMBL4768931,Antibacterial activity against Pseudomonas aeruginosa ATCC 9027,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765291,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
16530,,,22961764,[],CHEMBL4768932,Antibacterial activity against Bacillus proteus ATCC 8427,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765291,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565835,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,2.0
16531,,,22963644,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769030,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765295,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565941,=,1,1,=,,MIC,ug.mL-1,,1250.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1250.0
16532,,,22963645,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769030,Antibacterial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765295,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3565941,=,1,1,=,,MIC,nM,,3914446.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,3914.446
16533,,,22963728,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769031,Antibacterial activity against Streptococcus pyogenes ATCC 19615 incubated for 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765295,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565941,=,1,1,=,,MIC,ug.mL-1,,625.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,625.0
16534,,,22963729,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769031,Antibacterial activity against Streptococcus pyogenes ATCC 19615 incubated for 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765295,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3565941,=,1,1,=,,MIC,nM,,1957223.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,uM,UO_0000065,,1957.223
16535,,,22963810,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769032,Antibacterial activity against Salmonella typhimurium ATCC 19430 incubated for 18 hrs by agar dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765295,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565941,=,1,1,=,,MIC,ug.mL-1,,2.4,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,2.4
16536,,,22963811,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769032,Antibacterial activity against Salmonella typhimurium ATCC 19430 incubated for 18 hrs by agar dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765295,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3565941,=,1,1,=,,MIC,nM,,7516000.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,uM,UO_0000065,,7516.0
16537,,,22963896,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769033,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by agar dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765295,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3565941,=,1,1,=,,MIC,ug.mL-1,,4.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.8
16538,,,22963897,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4769033,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by agar dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4765295,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3565941,=,1,1,=,,MIC,nM,,15031000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,15031.0
16539,,,22975751,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771719,Antimicrobial activity against Escherichia coli NCTC 11954 producing penicillinase assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,,MIC,nM,,24400.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.0244
16540,,,22975760,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771720,Antimicrobial activity against Escherichia coli ATCC 8739 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,,MIC,nM,,48900.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.0489
16541,,,22975771,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771721,Antimicrobial activity against Escherichia coli O157:H7 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,<,1,1,<,,MIC,nM,,5900.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.0059
16542,,,22975780,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771722,Antimicrobial activity against fluoroquinolone-resistant Escherichia coli assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,,MIC,nM,,293700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.2937
16543,,,22975788,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771723,Antimicrobial activity against Salmonella enterica ATCC 13312 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,<,1,1,<,,MIC,nM,,5900.0,CHEMBL613762,Salmonella enterica,Salmonella enterica,28901.0,,,MIC,mM,UO_0000065,,0.0059
16544,,,22975797,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771724,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9627 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,,MIC,nM,,98000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.098
16545,,,22975805,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771725,Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,,MIC,nM,,24400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.0244
16546,,,22975814,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771726,Antimicrobial activity against methicillin-sensitive Staphylococcus aureus ATCC 9253 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,,MIC,nM,,24400.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.0244
16547,,,22975823,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771727,Antimicrobial activity against Listeria monocytogenes ATCC 19115 assessed as inhibition of microbial growth incubated for 24 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,<,1,1,<,,MIC,nM,,5900.0,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,mM,UO_0000065,,0.0059
16548,,,22975832,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4771728,Antifungal activity against Candida albicans ATCC 10231 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,<,1,1,<,,MIC,nM,,5900.0,CHEMBL366,Candida albicans,Candida albicans,5476.0,,,MIC,mM,UO_0000065,,0.0059
16549,,,22975843,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4771729,Antifungal activity against Aspergillus flavus ATCC 9643 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,,MIC,nM,,782900.0,CHEMBL614955,Aspergillus flavus,Aspergillus flavus,5059.0,,,MIC,mM,UO_0000065,,0.7829
16550,,,22975854,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4771730,Antifungal activity against Fusarium solani ATCC 36031 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,,MIC,nM,,391400.0,CHEMBL612506,Fusarium solani,Fusarium solani,169388.0,,,MIC,mM,UO_0000065,,0.3914
16551,,,22975864,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4771731,Antifungal activity against Stachybotrys chartarum IBT 7711 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,,MIC,nM,,195700.0,CHEMBL613284,Stachybotrys chartarum,Stachybotrys chartarum,74722.0,,,MIC,mM,UO_0000065,,0.1957
16552,,,22975874,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '48.0'}]",CHEMBL4771732,Antifungal activity against Penicillium chrysogenum ATCC 10106 assessed as reduction in fungal growth incubated for 48 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,,MIC,nM,,195700.0,CHEMBL612847,Penicillium chrysogenum,Penicillium chrysogenum,5076.0,,,MIC,mM,UO_0000065,,0.1957
16553,,,22975884,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4771733,Cytotoxicity against rat L6 cells assessed as inhibition of cell viability incubated for 24 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765367,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,5.46,0,http://www.openphacts.org/units/Nanomolar,3567995,=,1,1,=,,IC50,nM,,3431.1,CHEMBL614793,Rattus norvegicus,L6,10116.0,,,IC50,uM,UO_0000065,,3.4311
16554,,,22978407,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '200.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '200.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '5.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '5.0'}]",CHEMBL4772302,Effective permeability of the compound at 200 uM incubated for 5 hrs by PAMPA based UPLC/MS analysis,A,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4765382,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3568450,=,1,0,=,,Peff,10^-6 cm/s,,0.6,CHEMBL612558,,ADMET,,,,Peff,10^-6 cm/s,,,0.6
16555,,,23129749,[],CHEMBL4808149,Enzymatic assay of human HDAC6 with commercial peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL4808148,,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3592738,=,59,1,=,,Inhibition,%,,-43.91,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,-43.91
16556,,,23138380,[],CHEMBL4808150,Enzymatic assay of human HDAC6 with custom peptide substrate,B,,,BAO_0000201,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4808148,,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3592738,=,59,1,=,,Inhibition,%,,0.59,CHEMBL1865,Homo sapiens,Histone deacetylase 6,9606.0,,,inhibition,%,UO_0000187,,0.59
16557,,,23172245,[],CHEMBL4814646,Antibacterial activity against Escherichia coli by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813920,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3602922,=,1,1,=,,MIC,nM,,1605000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,1.605
16558,,,23172247,[],CHEMBL4814647,Antibacterial activity against Enterococcus faecalis by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813920,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3602922,=,1,1,=,,MIC,nM,,803000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mM,UO_0000065,,0.8029999999999999
16559,,,23172249,[],CHEMBL4814648,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813920,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3602922,=,1,1,=,,MIC,nM,,1605000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,1.605
16560,,,23172251,[],CHEMBL4814649,Antibacterial activity against Acinetobacter baumannii by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813920,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3602922,=,1,1,=,,MIC,nM,,803000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mM,UO_0000065,,0.8029999999999999
16561,,,23182519,[],CHEMBL4816900,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as reduction in microbial growth by two fold microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813987,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16562,,,23182541,[],CHEMBL4816901,Antibacterial activity against Staphylococcus aureus assessed as reduction in microbial growth by two fold microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813987,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16563,,,23182563,[],CHEMBL4816902,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in microbial growth by two fold microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813987,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16564,,,23182585,[],CHEMBL4816903,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as reduction in microbial growth by two fold microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813987,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16565,,,23182607,[],CHEMBL4816904,Antibacterial activity against Enterococcus faecalis assessed as reduction in microbial growth by two fold microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813987,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
16566,,,23182629,[],CHEMBL4816905,Antibacterial activity against Klebsiella pneumonia assessed as reduction in microbial growth by two fold microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813987,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16567,,,23182651,[],CHEMBL4816906,Antibacterial activity against Acinetobacter baumannii assessed as reduction in microbial growth by two fold microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813987,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
16568,,,23182673,[],CHEMBL4816907,Antibacterial activity against Escherichia coli assessed as reduction in microbial growth by two fold microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813987,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
16569,,,23182695,[],CHEMBL4816908,Antibacterial activity against Escherichia coli ATCC 25922 assessed as reduction in microbial growth by two fold microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813987,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
16570,,,23182717,[],CHEMBL4816909,Antibacterial activity against Pseudomonas aeruginosa assessed as reduction in microbial growth by two fold microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813987,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16571,,,23182739,[],CHEMBL4816910,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as reduction in microbial growth by two fold microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4813987,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3604680,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
16572,,,23188179,[],CHEMBL4818005,Antibacterial activity against methicillin-resistant Staphylococcus aureus by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16573,,,23188196,[],CHEMBL4818006,Antibacterial activity against Enterococcus faecalis by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
16574,,,23188213,[],CHEMBL4818007,Antibacterial activity against Staphylococcus aureus by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16575,,,23188230,[],CHEMBL4818008,Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16576,,,23188247,[],CHEMBL4818009,Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16577,,,23188264,[],CHEMBL4818010,Antibacterial activity against Klebsiella pneumonia by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,16.0
16578,,,23188281,[],CHEMBL4818011,Antibacterial activity against Escherichia coli by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16579,,,23188298,[],CHEMBL4818012,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16580,,,23188315,[],CHEMBL4818013,Antibacterial activity against Pseudomonas aeruginosa by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
16581,,,23188332,[],CHEMBL4818014,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
16582,,,23188349,[],CHEMBL4818015,Antibacterial activity against Acinetobacter baumannii by broth microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3605760,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
16583,,Not Active,23188353,[],CHEMBL4818017,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as reduction in bacterial growth measured after 16 passages,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814033,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3605760,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16584,,,23189663,[],CHEMBL4818352,Antibacterial activity against methicillin resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16585,,,23189684,[],CHEMBL4818353,Antibacterial activity against Enterococcus faecalis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
16586,,,23189705,[],CHEMBL4818354,Antibacterial activity against Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16587,,,23189726,[],CHEMBL4818355,Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16588,,,23189747,[],CHEMBL4818356,Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16589,,,23189768,[],CHEMBL4818357,Antibacterial activity against Klebsiella pneumonia by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16590,,,23189789,[],CHEMBL4818358,Antibacterial activity against Escherichia coli by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
16591,,,23189810,[],CHEMBL4818359,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16592,,,23189831,[],CHEMBL4818360,Antibacterial activity against Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16593,,,23189852,[],CHEMBL4818361,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16594,,,23189873,[],CHEMBL4818362,Antibacterial activity against Acinetobacter baumannii by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3606158,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
16595,,Not Active,23189880,[],CHEMBL4818368,Antibacterial activity against Escherichia coli ATCC 25922 measured after 6 passages by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4814052,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3606158,,1,0,,,Activity,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,,,,
16596,,,23214442,[],CHEMBL4823061,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16597,,,23214466,[],CHEMBL4823062,Antibacterial activity against Enterococcus faecalis assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,256.0
16598,,,23214490,[],CHEMBL4823063,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16599,,,23214514,[],CHEMBL4823064,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16600,,,23214538,[],CHEMBL4823065,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16601,,,23214562,[],CHEMBL4823066,Antibacterial activity against Klebsiella pneumonia assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,256.0
16602,,,23214586,[],CHEMBL4823067,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
16603,,,23214610,[],CHEMBL4823068,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,256.0
16604,,,23214634,[],CHEMBL4823069,Antibacterial activity against Acinetobacter baumannii assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
16605,,,23214658,[],CHEMBL4823070,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
16606,,,23214682,[],CHEMBL4823071,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3610555,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
16607,,Not Active,23214689,[],CHEMBL4823076,Antibacterial activity against methicillin-resistant Staphylococcus aureus measured after 13 passages by broth microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4819149,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3610555,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16608,,,23220348,[],CHEMBL4824557,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,,MIC,nM,,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.025
16609,,,23220363,[],CHEMBL4824558,Antibacterial activity against Enterococcus faecalis by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,,MIC,nM,,25000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mM,UO_0000065,,0.025
16610,,,23220378,[],CHEMBL4824559,Antibacterial activity against Staphylococcus aureus by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,,MIC,nM,,6000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.006
16611,,,23220393,[],CHEMBL4824560,Antibacterial activity against Staphylococcus aureus ATCC 25923 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,,MIC,nM,,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.003
16612,,,23220408,[],CHEMBL4824561,Antibacterial activity against Staphylococcus aureus ATCC 29213 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,,MIC,nM,,6000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.006
16613,,,23220423,[],CHEMBL4824562,Antibacterial activity against Klebsiella pneumonia by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,,MIC,nM,,13000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mM,UO_0000065,,0.013
16614,,,23220438,[],CHEMBL4824563,Antibacterial activity against Escherichia coli by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,,MIC,nM,,50000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.05
16615,,,23220453,[],CHEMBL4824564,Antibacterial activity against Pseudomonas aeruginosa by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,,MIC,nM,,25000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.025
16616,,,23220468,[],CHEMBL4824565,Antibacterial activity against Acinetobacter baumannii by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,,MIC,nM,,25000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mM,UO_0000065,,0.025
16617,,,23220483,[],CHEMBL4824566,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,,MIC,nM,,3000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.003
16618,,,23220498,[],CHEMBL4824567,Antibacterial activity against Escherichia coli ATCC 25922 by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3611638,=,1,1,=,,MIC,nM,,25000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.025
16619,,,23220511,[],CHEMBL4824580,Potentiation of (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one-induced antibacterial activity against methicillin resistant Staphylococcus aureus N315 assessed as (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one MIC,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3611638,=,1,0,=,,MIC,10^-3mM,,0.781,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,10^-3mM,,,0.7809999999999999
16620,,,23220512,[],CHEMBL4824581,Potentiation of (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one-induced antibacterial activity against Enterococcus faecalis assessed as (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one MIC,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3611638,=,1,0,=,,MIC,10^-3mM,,0.781,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,10^-3mM,,,0.7809999999999999
16621,,,23220513,[],CHEMBL4824582,Potentiation of(Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one-induced antibacterial activity against Klebsiella pneumoniae assessed as (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one MIC,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3611638,=,1,0,=,,MIC,10^-3mM,,0.203,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,10^-3mM,,,0.203
16622,,,23220514,[],CHEMBL4824583,Potentiation of (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one-induced antibacterial activity against Escherichia coli assessed as (Z)-4-((bis(2-hydroxyethyl)amino)methyl)-7-((1-(4-methoxyphenyl)-3-oxo-3-(thiazol-2-yl)prop-1-en-2-yl)oxy)-2H-chromen-2-one MIC,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4823277,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3611638,=,1,0,=,,MIC,10^-3mM,,0.781,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,10^-3mM,,,0.7809999999999999
16623,,,23235882,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4828077,Antibacterial activity against wild-type Staphylococcus aureus SA-1199 incubated for 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4825750,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3614641,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
16624,,,23235884,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL4828078,Antibacterial activity against Staphylococcus aureus SA-1199B overexpressing NorA incubated for 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4825750,Bioorg Med Chem Lett,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3614641,=,1,1,=,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
16625,,,23241096,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829245,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16626,,,23241136,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829246,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 43300 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
16627,,,23241179,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829247,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 62202 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16628,,,23241219,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829248,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 52056 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16629,,,23241259,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829249,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC513045 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
16630,,,23241299,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829250,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC515992 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
16631,,,23241339,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829251,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC49800 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16632,,,23241379,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829252,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC49025 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16633,,,23241419,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829253,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC48073 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16634,,,23241459,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829254,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC48966 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16635,,,23241499,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829255,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC49008 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16636,,,23241539,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829256,Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC48706 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16637,,,23241579,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829257,Antibacterial activity against Escherichia coli ATCC25922 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
16638,,,23241619,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829258,Antibacterial activity against Pseudomonas aeruginosa ATCC27853 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
16639,,,23241659,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL4829259,Antibacterial activity against Enterococcus faecalis ATCC29212 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4828717,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3615600,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,32.0
16640,,,23313106,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '5.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '5.0'}]",CHEMBL4844518,Permeability coefficient of the compound in PBS buffer incubated for 5 hrs by PAMPA-based LC-MS analysis,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL4842370,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3628431,=,1,0,=,,permeability,10^-6 cm/s,,0.056,CHEMBL612558,,ADMET,,,,permeability,10^-6 cm/s,,,0.0559999999999999
16641,,Not Determined,24350825,[],CHEMBL5032114,Antimicrobial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5030557,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3772642,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
16642,,Not Determined,24350832,[],CHEMBL5032115,Antimicrobial activity against Bacillus subtilis ATCC 6633 assessed as inhibition of bacterial growth by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5030557,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3772642,,1,0,,,MIC,,,,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,,,,
16643,,,24350839,[],CHEMBL5032116,Antimicrobial activity against Klebsiella pneumoniae ATCC 27736 assessed as inhibition of bacterial growth by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5030557,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3772642,=,1,1,=,,MIC,nM,,150.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,uM,UO_0000065,,0.15
16644,,,24350846,[],CHEMBL5032117,Antimicrobial activity against Pseudomonas aeruginosa ATCC BAA-427 assessed as inhibition of bacterial growth by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5030557,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3772642,=,1,1,=,,MIC,nM,,1220.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,1.22
16645,,,24350865,[],CHEMBL5032124,Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5030557,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3772642,=,1,1,=,,MIC,nM,,1220.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,1.22
16646,,Not Determined,24350872,[],CHEMBL5032125,Antimicrobial activity against methicilin- resistant Staphylococcus aureus ATCC 33591 assessed as inhibition of bacterial growth by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5030557,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3772642,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
16647,,,24350879,[],CHEMBL5032126,Antimicrobial activity against multidrug-resistant Staphylococcus aureus ATCC BAA-44 assessed as inhibition of bacterial growth by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5030557,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3772642,=,1,1,=,,MIC,nM,,2440.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,2.44
16648,,Not Determined,24350886,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.6667', 'text_value': None, 'type': 'Time', 'units': 'min', 'value': '40.0'}]",CHEMBL5032127,Hemolytic activity in human RBC measured after 40 mins,A,,,BAO_0000179,BAO_0000221,tissue-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5030557,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3772642,,1,0,,,HC50,,,,CHEMBL612545,,Unchecked,,,,HC50,,,,
16649,,,24374427,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036802,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16650,,,24374456,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036803,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
16651,,,24374485,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036804,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16652,,,24374514,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036805,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16653,,,24374543,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036806,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16654,,,24374572,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microg/ml', 'standard_value': '512.0', 'text_value': None, 'type': 'Dose', 'units': 'microg/ml', 'value': '512.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036807,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
16655,,,24374601,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036808,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
16656,,,24374630,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036809,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
16657,,,24374659,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036810,Antibacterial activity against Acinetobacter baumanii assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
16658,,,24374688,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036811,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
16659,,,24374717,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036812,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth measured after 24 hrs by two-fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3776167,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
16660,,,24374762,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036830,Antibacterial activity against Escherichia coli assessed as drug resistance by measuring fold change in MIC treated for 16 serial passages and measured every 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3776167,=,1,0,=,,FC,,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FC,,,,32.0
16661,,,24374763,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5036831,Antibacterial activity against Pseudomonas aeruginosa assessed as drug resistance by measuring fold change in MIC treated for 16 serial passages and measured every 24 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036317,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3776167,=,1,0,=,,FC,,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,32.0
16662,,Active,24377782,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5037689,Induction of drug resistance in Staphylococcus aureus ATCC29213 assessed as reduction in bacterial growth at 0.5 times MIC measured after 24 hr,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5036339,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3776624,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16663,,,24391944,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5041482,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,,MIC,nM,,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.025
16664,,,24391970,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5041483,Antibacterial activity against Enterococcus faecalis assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,,MIC,nM,,6000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mM,UO_0000065,,0.006
16665,,,24391996,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5041484,Antibacterial activity against Staphylococcus aureus assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,,MIC,nM,,2000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.002
16666,,,24392022,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5041485,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,,MIC,nM,,13000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.013
16667,,,24392048,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5041486,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,,MIC,nM,,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.1
16668,,,24392074,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5041487,Antibacterial activity against Klebsiella pneumoniae assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,,MIC,nM,,6000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mM,UO_0000065,,0.006
16669,,,24392100,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5041488,Antibacterial activity against Escherichia coli assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,,MIC,nM,,13000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.013
16670,,,24392126,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5041489,Antibacterial activity against Pseudomonas aeruginosa assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,,MIC,nM,,25000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.025
16671,,,24392152,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5041490,Antibacterial activity against Acinetobacter baumannii assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,,MIC,nM,,6000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mM,UO_0000065,,0.006
16672,,,24392178,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5041491,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,,MIC,nM,,200000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.2
16673,,,24392204,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5041492,Antibacterial activity against Escherichia coli ATCC 25922 assessed as decrease in bacterial growth incubated for 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3779183,=,1,1,=,,MIC,nM,,13000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.013
16674,,,24392248,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '384.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '16.0'}]",CHEMBL5041502,Induction of bacterial resistance in Escherichia coli assessed as fold increase in MIC measured after 16 days by resistance development assay,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5038640,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3779183,=,1,0,=,,FC,,,64.0,CHEMBL612545,,Unchecked,,,,FC,,,,64.0
16675,,Not Active,24400049,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043610,Antibacterial activity against methicillin resistant Staphylococcus aureus treated over 10 serial passages measured after 24 hrs by resistance development assay,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3780926,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16676,,,24400059,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043611,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16677,,,24400089,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043612,Antibacterial activity against Enterococcus faecium assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,,MIC,ug ml-1,UO_0000274,,8.0
16678,,,24400119,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043613,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16679,,,24400149,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043614,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16680,,,24400179,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043615,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16681,,,24400209,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043616,Antibacterial activity against Klebsiella pneumoniae assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16682,,,24400238,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043617,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
16683,,,24400267,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043618,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
16684,,,24400296,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043619,Antibacterial activity against Acinetobacter baumannii assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
16685,,,24400325,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043620,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16686,,,24400354,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5043621,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition measured after 24 hrs by two fold serial dilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
16687,"{'action_type': 'POSITIVE ALLOSTERIC MODULATOR', 'description': 'Enhances the action of the endogenous ligand of a receptor through binding to a site distinct from that ligand', 'parent_type': 'POSITIVE MODULATOR'}",,24400416,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '6.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '6.0'}]",CHEMBL5043639,Binding affinity to Staphylococcus aureus PBP2a measured after 6 hrs by ELISA,B,,,BAO_0000181,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5042496,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3780926,=,1,0,=,,Activity,ug ml-1,,7.67,CHEMBL612545,,Unchecked,,,,Activity,ug ml-1,UO_0000274,,7.67
16688,,,24513086,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5056331,Antimicrobial activity against Pseudomonas aeruginosa PA01 assessed as inhibition of microbial growth measured after 24 hrs by broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5055634,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3838216,=,1,1,=,,MIC,ug.mL-1,,4.16,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.16
16689,,,24513100,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5056332,Antitumour activity against dox resistant human MCF7/ADR cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5055634,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.7,0,http://www.openphacts.org/units/Nanomolar,3838216,=,1,1,=,,IC50,nM,,20060.0,CHEMBL613829,Homo sapiens,NCI/ADR-RES,9606.0,,,IC50,uM,UO_0000065,,20.06
16690,,,24513115,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5056333,Cytotoxicity against human WH1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5055634,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.85,0,http://www.openphacts.org/units/Nanomolar,3838216,=,1,1,=,,IC50,nM,,14070.0,CHEMBL612545,,Unchecked,,,,IC50,uM,UO_0000065,,14.07
16691,,,24513129,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5056334,Cytotoxicity against human HBL-100 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,A,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5055634,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.91,0,http://www.openphacts.org/units/Nanomolar,3838216,=,1,1,=,,IC50,nM,,12430.0,CHEMBL614811,Homo sapiens,HBL-100,9606.0,,,IC50,uM,UO_0000065,,12.43
16692,,,24513155,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5056337,Antitumor activity against human MCF7 cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5055634,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.71,0,http://www.openphacts.org/units/Nanomolar,3838216,=,1,1,=,,IC50,nM,,19370.0,CHEMBL387,Homo sapiens,MCF7,9606.0,,,IC50,uM,UO_0000065,,19.37
16693,,,24513200,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5056348,"Resistance index, ratio of IC50 for antitumor activity against human MCF7 cells to IC50 for antitumour activity against dox resistant human MCF7/ADR cells assessed as cell growth inhibition incubated for 72 hrs by MTT assay",F,,,BAO_0000179,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5055634,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3838216,=,1,0,=,,Ratio IC50,,,1.0,CHEMBL612545,,Unchecked,,,,Ratio IC50,,,,1.0
16694,,,24690717,[],CHEMBL5105660,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as bacterial growth inhibition by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16695,,,24690736,[],CHEMBL5105661,Antibacterial activity against Enterococcus faecalis assessed as bacterial growth inhibition by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
16696,,,24690755,[],CHEMBL5105662,Antibacterial activity against Staphylococcus aureus assessed as bacterial growth inhibition by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16697,,,24690774,[],CHEMBL5105663,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16698,,,24690793,[],CHEMBL5105664,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16699,,,24690812,[],CHEMBL5105665,Antibacterial activity against Klebsiella pneumoniae assessed as bacterial growth inhibition by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16700,,,24690831,[],CHEMBL5105666,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16701,,,24690850,[],CHEMBL5105667,Antibacterial activity against Escherichia coli ATCC 25922 assessed as bacterial growth inhibition by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16702,,,24690869,[],CHEMBL5105668,Antibacterial activity against Pseudomonas aeruginosa assessed as bacterial growth inhibition by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
16703,,,24690888,[],CHEMBL5105669,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as bacterial growth inhibition by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
16704,,,24690907,[],CHEMBL5105670,Antibacterial activity against Acinetobacter baumannii assessed as bacterial growth inhibition by serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3849820,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
16705,,,24690948,[],CHEMBL5105684,Induction of drug resistance in Enterococcus faecalis assessed as fold increase in MIC measured for 16 passages relative to control,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104131,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3849820,=,1,0,=,,FC,,,7.0,CHEMBL612545,,Unchecked,,,,FC,,,,7.0
16706,,Active,24702808,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'microg/ml', 'standard_value': '25.0', 'text_value': None, 'type': 'Dose_Lower', 'units': 'microg/ml', 'value': '25.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'microg/ml', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'microg/ml', 'value': '50.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5107856,Effect on DNA damage repair in Caulobacter vibrioides expressing Gam-GFP reporter system assessed as increase in double stranded break by measuring Gam localization in cells at 25 to 50 ug/ml and measured after 2 hrs by fluorescence analysis,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104228,RSC Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3851949,,1,0,,,Activity,,,,CHEMBL612285,Caulobacter vibrioides,Caulobacter vibrioides,155892.0,,,Activity,,,,
16707,,Active,24702822,"[{'comments': None, 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microg/ml', 'standard_value': '1.0', 'text_value': None, 'type': 'Dose', 'units': 'microg/ml', 'value': '1.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '2.0'}]",CHEMBL5107862,Effect on DNA damage repair in Caulobacter vibrioides lacking uvrA expression assessed as decrease in cell survival rate upto 1 ug/ml and measured after 2 days by agar dilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5104228,RSC Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3851949,,1,0,,,Activity,,,,CHEMBL612285,Caulobacter vibrioides,Caulobacter vibrioides,155892.0,,,Activity,,,,
16708,,,24713174,[],CHEMBL5110689,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 measured by Muller-Hinton broth based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16709,,,24713224,[],CHEMBL5110690,Antibacterial activity against Enterococcus faecalis measured by Muller-Hinton broth based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,8.0
16710,,,24713274,[],CHEMBL5110691,Antibacterial activity against Staphylococcus aureus measured by Muller-Hinton broth based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16711,,,24713324,[],CHEMBL5110692,Antibacterial activity against Staphylococcus aureus ATCC 25923 measured by Muller-Hinton broth based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16712,,,24713374,[],CHEMBL5110693,Antibacterial activity against Staphylococcus aureus ATCC 29213 measured by Muller-Hinton broth based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16713,,,24713424,[],CHEMBL5110694,Antibacterial activity against Klebsiella pneumoniae measured by Muller-Hinton broth based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16714,,,24713473,[],CHEMBL5110695,Antibacterial activity against Escherichia coli measured by Muller-Hinton broth based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
16715,,,24713522,[],CHEMBL5110696,Antibacterial activity against Pseudomonas aeruginosa measured by Muller-Hinton broth based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
16716,,,24713571,[],CHEMBL5110697,Antibacterial activity against Acinetobacter baumannii measured by Muller-Hinton broth based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
16717,,,24713620,[],CHEMBL5110698,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 measured by Muller-Hinton broth based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16718,,,24713669,[],CHEMBL5110699,Antibacterial activity against Escherichia coli ATCC 25922 measured by Muller-Hinton broth based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3854319,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
16719,,,24713729,[],CHEMBL5110705,Antibacterial activity against Staphylococcus aureus assessed as fold increase in MIC measured after 16 passages by resistance development assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3854319,=,1,0,=,,FC,,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,64.0
16720,,,24713732,[],CHEMBL5110707,Antibacterial activity against Pseudomonas aeruginosa assessed as fold increase in MIC measured after 16 passages by resistance development assay,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108027,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3854319,=,1,0,=,,FC,,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FC,,,,128.0
16721,,,24721691,[],CHEMBL5112941,Induction of resistant development in Staphylococcus aureus ATCC 29213 assessed as fold increase in MIC at 0.5 MIC after 12 passages by resistant development assay,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5108078,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3855747,=,1,0,=,,FC,,,32.0,CHEMBL612545,,Unchecked,,,,FC,,,,32.0
16722,,,24741967,[],CHEMBL5118045,Antibacterial activity against Staphylococcus aureus ATCC 43300 assessed as resistance development by measuring fold increase in MIC,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5113489,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3859625,=,1,0,=,,FC,,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,256.0
16723,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,24762591,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microM', 'standard_value': '20.0', 'text_value': None, 'type': 'Dose', 'units': 'microM', 'value': '20.0'}]",CHEMBL5124224,Inhibition of wild type full length miR-21 in human HeLa cells co-expressing firefly luciferase and renilla luciferase gene assessed as fold change in Luc/Rlu by measuring relative fluorescence intensity at 20 uM by Dual-Luciferase reporter based luminometer analysis,B,,,BAO_0000179,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5120871,Bioorg Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3863615,=,1,0,=,,FC,,,1.08,CHEMBL1615322,Homo sapiens,microRNA 21,9606.0,,,FC,,,,1.08
16724,,,24770356,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5126060,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5120961,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864923,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16725,,,24770369,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5126061,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5120961,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3864923,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16726,,ND,24770382,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'Time_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Time_Upper', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'Time_Upper', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5126062,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated for 16 to 18 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5120961,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3864923,,1,0,,,MIC,,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,,,,
16727,,ND,24770395,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '1.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '1.0'}]",CHEMBL5126063,Hemolytic activity in rabbit erythrocytes incubated for 1 hr,T,,,BAO_0000179,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5120961,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3864923,,1,0,,,HC5,,,,CHEMBL4296518,,Erythrocyte,,,,HC5,,,,
16728,,,24802524,[],CHEMBL5135147,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16729,,,24802556,[],CHEMBL5135149,Antibacterial activity against methicillin resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16730,,,24802587,[],CHEMBL5135150,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
16731,,,24802618,[],CHEMBL5135151,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16732,,,24802649,[],CHEMBL5135152,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16733,,,24802680,[],CHEMBL5135153,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16734,,,24802711,[],CHEMBL5135154,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
16735,,,24802742,[],CHEMBL5135155,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
16736,,,24802773,[],CHEMBL5135156,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,1.0
16737,,,24802804,[],CHEMBL5135157,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,4.0
16738,,,24802835,[],CHEMBL5135158,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3871964,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,4.0
16739,,,24802840,[],CHEMBL5135163,Induction of drug resistance in Acinetobacter baumannii assessed as fold increase in MIC value measured after 14 passage by resistance assay,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5131495,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3871964,=,1,0,=,,FC,,,16.0,CHEMBL612545,,Unchecked,,,,FC,,,,16.0
16740,,,24835448,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '16.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '16.0'}]",CHEMBL5144386,Permeability of the compound in PBS/EtOH buffer (7:3) incubated for 16 hrs by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143522,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3878977,=,1,0,=,,permeability,10^-6 cm/s,,1.1,CHEMBL612558,,ADMET,,,,permeability,10^-6 cm/s,,,1.1
16741,,,24838921,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5144980,Antibacterial activity against Staphylococcus aureus 1199B measured after 24 hrs by Muller Hinton broth based MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143555,Bioorg Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879623,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,50.0
16742,,,24838953,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5144981,Antibacterial activity against Staphylococcus aureus 1199 measured after 24 hrs by Muller Hinton broth based MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143555,Bioorg Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879623,=,1,1,=,,MIC,ug.mL-1,,1.56,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.56
16743,,,24838982,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5144982,Antibacterial activity against Staphylococcus aureus K1758 measured after 24 hrs by Muller Hinton broth based MTT assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143555,Bioorg Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3879623,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
16744,,Active,24839139,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microg/ml', 'standard_value': '50.0', 'text_value': None, 'type': 'Dose', 'units': 'microg/ml', 'value': '50.0'}]",CHEMBL5144993,Bactericidal activity against Staphylococcus aureus 1199B at 50 ug/mL by time-kill kinetics assay,F,,,BAO_0000201,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143555,Bioorg Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Percent,3879623,,1,0,,,Inhibition,%,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,INH,,UO_0000187,,
16745,,,24839140,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microg/ml', 'standard_value': '3.1', 'text_value': None, 'type': 'Dose', 'units': 'microg/ml', 'value': '3.1'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5144994,Bactericidal activity against Staphylococcus aureus 1199B assessed as bacterial count at 3.1 ug/mL measured after 24 hrs by time-kill kinetics assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143555,Bioorg Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3879623,=,1,0,=,,Activity,log10CFU/ml,,6.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,log10CFU/ml,,,6.0
16746,,,24839182,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microg/ml', 'standard_value': '1.55', 'text_value': None, 'type': 'Dose', 'units': 'microg/ml', 'value': '1.55'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '2.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '2.0'}]",CHEMBL5145018,Up regulation of NorA gene expression in Staphylococcus aureus 1199B at 1.55 ug/ml measured after 2 hrs by qRT-PCR analysis relative to control,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143555,Bioorg Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3879623,=,1,0,=,,FC,,,0.076,CHEMBL612545,,Unchecked,,,,FC,,,,0.076
16747,,,24839194,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Lower', 'standard_units': 'microg/ml', 'standard_value': '0.015', 'text_value': None, 'type': 'Dose_Lower', 'units': 'microg/ml', 'value': '0.015'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose_Upper', 'standard_units': 'microg/ml', 'standard_value': '8.0', 'text_value': None, 'type': 'Dose_Upper', 'units': 'microg/ml', 'value': '8.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5145026,Bactericidal activity against Staphylococcus aureus 1199B infected in human THP-1 cells assessed as reduction in bacterial count at 0.015 to 8 ug/ml measured after 24 hrs,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143555,Bioorg Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3879623,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16748,,,24840832,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'Dose', 'standard_units': 'microg/ml', 'standard_value': '100.0', 'text_value': None, 'type': 'Dose', 'units': 'microg/ml', 'value': '100.0'}]",CHEMBL5145520,Permeability of compound at 100 ug/mL by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143570,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3880055,=,1,0,=,,permeability,10^-6 cm/s,,0.11,CHEMBL612558,,ADMET,,,,permeability,10^-6 cm/s,,,0.11
16749,,,24842065,[],CHEMBL5145753,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,16.0
16750,,,24842093,[],CHEMBL5145754,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
16751,,,24842121,[],CHEMBL5145755,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16752,,,24842149,[],CHEMBL5145756,Antibacterial activity against Staphylococcus aureus 25923 assessed as inhibition of bacterial growth by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16753,,,24842177,[],CHEMBL5145757,Antibacterial activity against Staphylococcus aureus 29213 assessed as inhibition of bacterial growth by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16754,,,24842205,[],CHEMBL5145758,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16755,,,24842233,[],CHEMBL5145759,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
16756,,,24842261,[],CHEMBL5145760,Antibacterial activity against Escherichia coli 25922 assessed as inhibition of bacterial growth by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16757,,,24842289,[],CHEMBL5145761,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16758,,,24842317,[],CHEMBL5145762,Antibacterial activity against Pseudomonas aeruginosa 27853 assessed as inhibition of bacterial growth by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.5
16759,,,24842345,[],CHEMBL5145763,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth by two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3880338,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
16760,,,24842354,[],CHEMBL5145770,Bactericidal activity against Acinetobacter baumannii assessed as fold increase in MIC value after 16 passages by two fold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3880338,=,1,0,=,,FC,,,32.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,FC,,,,32.0
16761,,,24842355,[],CHEMBL5145771,Bactericidal activity against Klebsiella pneumoniae assessed as fold increase in MIC value after 16 passages by two fold serial dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143590,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3880338,=,1,0,=,,FC,,,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,FC,,,,32.0
16762,,,24847204,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146986,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16763,,,24847232,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146987,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,4.0
16764,,,24847260,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146988,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16765,,,24847288,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146989,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16766,,,24847316,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146990,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16767,,,24847344,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146991,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,8.0
16768,,,24847372,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146992,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
16769,,,24847400,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146993,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16770,,,24847428,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146994,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16771,,,24847456,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5146995,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3881343,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
16772,,,24847466,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '384.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '16.0'}]",CHEMBL5147005,Induction of drug resistance in Escherichia coli ATCC 25922 assessed as fold increase in MIC measured after 16 days by CLSI protocol based broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3881343,=,1,0,=,,FC,,,32.0,CHEMBL612545,,Unchecked,,,,FC,,,,32.0
16773,,,24847467,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '384.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '16.0'}]",CHEMBL5147006,Induction of drug resistance in Enterococcus faecalis assessed as fold increase in MIC measured after 16 days by CLSI protocol based broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5143638,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3881343,=,1,0,=,,FC,,,32.0,CHEMBL612545,,Unchecked,,,,FC,,,,32.0
16774,,,24866609,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5151747,Antibacterial activity against vancomycin resistant Enterococcus incubated for 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5149998,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3885471,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL612318,Enterococcus,Enterococcus,1350.0,,,MIC,ug ml-1,UO_0000274,,4.0
16775,,,24866618,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5151749,Antibacterial activity against methicillin resistant Staphylococcus aureus incubated for 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5149998,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3885471,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
16776,,,24912745,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163877,Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
16777,,,24912781,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163878,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,2.0
16778,,,24912817,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163879,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16779,,,24912853,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163880,Antibacterial activity against Staphylococcus aureus 25923 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16780,,,24912889,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163881,Antibacterial activity against Staphylococcus aureus 29213 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
16781,,,24912925,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163882,Antibacterial activity against Klebsiella pneumonia assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,4.0
16782,,,24912960,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163883,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
16783,,,24912995,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163884,Antibacterial activity against Escherichia coli 25922 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,2.0
16784,,,24913030,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163885,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,8.0
16785,,,24913065,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163886,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
16786,,,24913100,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'Time', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5163887,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth incubated for 24 hrs by CLSI protocol based two fold serial dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154842,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3893675,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,128.0
16787,,,24920141,[],CHEMBL5166024,Permeability of the compound by PAMPA-BBB assay,A,,,BAO_0002808,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5154888,Eur J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3895006,=,1,0,=,,permeability,10^-6 cm/s,,8.8,CHEMBL612558,,ADMET,,,,permeability,10^-6 cm/s,,,8.8
16788,,,24960718,[],CHEMBL5215624,Induction of drug resistance in Staphylococcus aureus ATCC 29213 assessed as fold change in MIC measured after 19 passages by CLSI based broth dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214900,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3899010,=,1,0,=,,FC,,,32.0,CHEMBL612545,,Unchecked,,,,FC,,,,32.0
16789,,,24961672,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '408.0', 'text_value': None, 'type': 'Time', 'units': 'day', 'value': '17.0'}]",CHEMBL5215971,Induction of drug resistance in Staphylococcus aureus ATCC 29213 assessed as fold change in MIC incubated for 17 days,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214910,J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3899184,=,1,0,=,,FC,,,32.0,CHEMBL612545,,Unchecked,,,,FC,,,,32.0
16790,,,24965354,[],CHEMBL5217013,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,,MIC,nM,,3000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.003
16791,,,24965367,[],CHEMBL5217014,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,,MIC,nM,,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.025
16792,,,24965380,[],CHEMBL5217015,Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,,MIC,nM,,6000.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,mM,UO_0000065,,0.006
16793,,,24965393,[],CHEMBL5217016,Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,,MIC,nM,,25000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.025
16794,,,24965406,[],CHEMBL5217017,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,,MIC,nM,,100000.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mM,UO_0000065,,0.1
16795,,,24965419,[],CHEMBL5217018,Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,,MIC,nM,,25000.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,mM,UO_0000065,,0.025
16796,,,24965432,[],CHEMBL5217019,Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,,MIC,nM,,50000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.05
16797,,,24965445,[],CHEMBL5217020,Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,,MIC,nM,,25000.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mM,UO_0000065,,0.025
16798,,,24965458,[],CHEMBL5217021,Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,,MIC,nM,,50000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.05
16799,,,24965471,[],CHEMBL5217022,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,,MIC,nM,,12000.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,mM,UO_0000065,,0.012
16800,,,24965484,[],CHEMBL5217023,Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth by CLSI based continuous dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3900408,=,1,1,=,,MIC,nM,,25000.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,mM,UO_0000065,,0.025
16801,,Active,24965540,[],CHEMBL5217043,Induction of drug resistance in Pseudomonas aeruginosa assessed as reduction in susceptibility measured after 6 passages,F,,,BAO_0000375,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3900408,,1,0,,,Activity,,,,CHEMBL612545,,Unchecked,,,,Activity,,,,
16802,,,24965541,[],CHEMBL5217044,Induction of drug resistance in Pseudomonas aeruginosa assessed as fold increase in MIC measured after 11 passages,F,,,BAO_0000179,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5214952,Bioorg Med Chem Lett,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3900408,=,1,0,=,,FC,,,8.0,CHEMBL612545,,Unchecked,,,,FC,,,,8.0
16803,,,24983352,[],CHEMBL5226740,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905372,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16804,,,24983356,[],CHEMBL5226741,Antibacterial activity against Pseudomonas aeruginosa No.010,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905372,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,2.0
16805,,,24983360,[],CHEMBL5226742,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa 025,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905372,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
16806,,,24983364,[],CHEMBL5226743,Antibacterial activity against multidrug resistant Pseudomonas aeruginosa 034,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5226286,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3905372,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
16807,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25002714,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '0.3333', 'text_value': None, 'type': 'TIME', 'units': 'min', 'value': '20.0'}]",CHEMBL5233566,Inhibition of mushroom tyrosinase using L-DOPA as substrate incubated for 20 mins by microplate reader assay,B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5233214,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3911620,=,1,1,=,,IC50,ug.mL-1,,0.7,CHEMBL3318,Agaricus bisporus,Tyrosinase,5341.0,,,IC50,ug ml-1,UO_0000274,,0.7
16808,,,25002978,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233660,Anticancer activity against human SK-MEL3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3911709,>,1,1,>,,IC50,nM,,128000.0,CHEMBL614920,Homo sapiens,SK-MEL3,9606.0,,,IC50,uM,UO_0000065,,128.0
16809,,,25002992,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233661,Anticancer activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3911709,>,1,1,>,,IC50,nM,,128000.0,CHEMBL387,Homo sapiens,MCF7,9606.0,,,IC50,uM,UO_0000065,,128.0
16810,,,25003006,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233662,Anticancer activity against human A-431 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3911709,>,1,1,>,,IC50,nM,,128000.0,CHEMBL614069,Homo sapiens,A-431,9606.0,,,IC50,uM,UO_0000065,,128.0
16811,,,25003020,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233663,Anticancer activity against human EJ cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3911709,>,1,1,>,,IC50,nM,,128000.0,CHEMBL614292,Homo sapiens,EJ,9606.0,,,IC50,uM,UO_0000065,,128.0
16812,,,25003034,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233664,Anticancer activity against human KB cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3911709,>,1,1,>,,IC50,nM,,128000.0,CHEMBL398,Homo sapiens,KB,9606.0,,,IC50,uM,UO_0000065,,128.0
16813,,,25003048,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '72.0'}]",CHEMBL5233665,Anticancer activity against human SW480 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3911709,>,1,1,>,,IC50,nM,,128000.0,CHEMBL612544,Homo sapiens,SW480,9606.0,,,IC50,uM,UO_0000065,,128.0
16814,,,25003063,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5233667,Antitumor activity against mouse CT26 cells assessed as reduction in cell viability incubated for 4 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3911709,=,1,1,=,,IC50,nM,,330000.0,CHEMBL613866,Mus musculus,CT26,10090.0,,,IC50,mM,UO_0000065,,0.33
16815,,,25003073,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '4.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '4.0'}]",CHEMBL5233668,Antitumor activity against human A549 cells assessed as reduction in cell viability incubated for 4 hrs by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3911709,=,1,1,=,,IC50,nM,,330000.0,CHEMBL392,Homo sapiens,A549,9606.0,,,IC50,mM,UO_0000065,,0.33
16816,,,25003205,[],CHEMBL5233720,Antiproliferative activity against mouse L1210 cells assessed as reduction in cell viability by MTT assay,F,,,BAO_0000190,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5233217,Eur J Med Chem,2020.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3911709,>,1,1,>,,IC50,nM,,150000.0,CHEMBL386,Mus musculus,L1210,10090.0,,,IC50,uM,UO_0000065,,150.0
16817,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25005081,[],CHEMBL5234501,Inhibition of Escherichia coli DNA gyrase,B,,,BAO_0000190,BAO_0000223,protein complex format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5233247,Eur J Med Chem,2020.0,"{'bei': '14.81', 'le': '0.28', 'lle': '3.46', 'sei': '6.34'}",CHEMBL9,NORFLOXACIN,CHEMBL9,4.73,1,http://www.openphacts.org/units/Nanomolar,3912694,=,1,1,=,,IC50,nM,,18600.0,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,IC50,uM,UO_0000065,,18.6
16818,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",,25007370,[],CHEMBL5235458,Inhibition of BRD4 (unknown origin),B,,,BAO_0000190,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5233264,Eur J Med Chem,2021.0,"{'bei': '18.82', 'le': '0.36', 'lle': '4.74', 'sei': '8.06'}",CHEMBL9,NORFLOXACIN,CHEMBL9,6.01,0,http://www.openphacts.org/units/Nanomolar,3913464,=,1,1,=,,IC50,nM,,980.0,CHEMBL1163125,Homo sapiens,Bromodomain-containing protein 4,9606.0,,,IC50,uM,UO_0000065,,0.98
16819,,,25023507,[],CHEMBL5240095,Drug resistance development in Staphylococcus aureus ATCC 29213 assessed as fold change in MIC measured after 20 passages,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5236632,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3916906,=,1,0,=,,FC,,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,FC,,,,128.0
16820,,Active,25023869,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '2.0'}]",CHEMBL5240134,Induction of drug resistance in Staphylococcus aureus ATCC 29213 assessed as increase in MIC at 0.5 times MIC measured after 2 days by CLSI based microdilution method,F,,,BAO_0000375,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5236634,J Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,,3916967,,1,0,,,Activity,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,,,,
16821,,,25030487,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5241556,Antimicrobial activity against methicillin resistant Staphylococcus aureus 1 assessed as inhibition of bacterial growth incubated for 16 to 20 hrs by CLSI protocol based Muller-Hinton broth method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241069,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918999,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16822,,,25030496,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5241557,Antimicrobial activity against methicillin resistant Staphylococcus aureus 2 assessed as inhibition of bacterial growth incubated for 16 to 20 hrs by CLSI protocol based Muller-Hinton broth method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241069,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918999,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
16823,,,25030505,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '16.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '16.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5241558,Antimicrobial activity against methicillin resistant Staphylococcus aureus 3 assessed as inhibition of bacterial growth incubated for 16 to 20 hrs by CLSI protocol based Muller-Hinton broth method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241069,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3918999,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
16824,,,25032518,[],CHEMBL5242327,Antibacterial activity against Escherichia coli,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,,MIC,ug.mL-1,,0.24,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.24
16825,,,25032558,[],CHEMBL5242328,Antibacterial activity against Yersinia pseudotuberculosis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,,MIC,ug.mL-1,,0.24,CHEMBL613185,Yersinia pseudotuberculosis,Yersinia pseudotuberculosis,633.0,,,MIC,ug ml-1,UO_0000274,,0.24
16826,,,25032626,[],CHEMBL5242330,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,,MIC,ug.mL-1,,0.24,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.24
16827,,,25032676,[],CHEMBL5242331,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,,MIC,ug.mL-1,,0.24,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.24
16828,,,25032750,[],CHEMBL5242333,Antibacterial activity against Enterococcus faecalis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,,MIC,ug.mL-1,,0.24,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.24
16829,,,25032814,[],CHEMBL5242336,Antibacterial activity against Bacillus cereus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,<,1,1,<,,MIC,ug.mL-1,,0.24,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,ug ml-1,UO_0000274,,0.24
16830,,,25032900,[],CHEMBL5242352,Antibacterial activity against Salmonella typhi,F,,,BAO_0002146,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,=,1,1,=,,MIC,ug.mL-1,,2.4,CHEMBL612545,,Unchecked,,,,MIC,ug ml-1,UO_0000274,,2.4
16831,,,25032914,[],CHEMBL5242353,Antibacterial activity against Salmonella enteritidis,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241092,Eur J Med Chem,2021.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3919823,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,,MIC,ug ml-1,UO_0000274,,0.0625
16832,,,25035456,[],CHEMBL5243128,Antibacterial activity against Staphylococcus aureus assessed as diameter of inhibition zone,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3920816,=,1,1,=,,IZ,mm,,14.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,14.0
16833,,,25035469,[],CHEMBL5243129,Antibacterial activity against Bacillus subtilis assessed as diameter of inhibition zone,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3920816,=,1,1,=,,IZ,mm,,24.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,DIZ,mm,UO_0000016,,24.0
16834,,,25035480,[],CHEMBL5243130,Antibacterial activity against Escherichia coli assessed as diameter of inhibition zone,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3920816,=,1,1,=,,IZ,mm,,20.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,20.0
16835,,,25035494,[],CHEMBL5243131,Antibacterial activity against Salmonella typhimurium assessed as diameter of inhibition zone,F,,,BAO_0003039,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://qudt.org/vocab/unit#Millimeter,3920816,=,1,1,=,,IZ,mm,,16.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,DIZ,mm,UO_0000016,,16.0
16836,,,25035781,[],CHEMBL5243225,Antibacterial activity against Salmonella typhimurium MTCC 98 assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5241112,RSC Med Chem,2022.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3920816,=,1,1,=,,MIC,ug.mL-1,,10.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,10.0
16837,,,25040069,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5244529,Antimalarial activity against hepatic stage Plasmodium yoelii yoelii 265 BY for 48 hrs with media renew every 24 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922422,=,1,1,=,,IC50,ug.mL-1,,17.8,CHEMBL612328,Plasmodium yoelii yoelii,Plasmodium yoelii yoelii,73239.0,,,IC50,ug ml-1,UO_0000274,,17.8
16838,,,25040093,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244530,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum NF54-R infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922422,=,1,1,=,,IC50,ug.mL-1,,6.7,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,6.7
16839,,,25040119,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '96.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '96.0'}]",CHEMBL5244531,Antimalarial activity against blood stage chloroquine-sensitive Plasmodium falciparum 3D7 infected in erythrocytes assessed as reduction in parasite growth preincubated for 72 hrs followed by addition of [3H]Hypoxanthine and measured after 24 hrs by liquid scintillation counting method,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922422,=,1,1,=,,IC50,ug.mL-1,,17.2,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,17.2
16840,,,25040142,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5244532,Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCC1 measured after 48 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,620000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,620.0
16841,,,25040148,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '48.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '48.0'}]",CHEMBL5244533,Antimalarial activity against chloroquine-resistant Plasmodium falciparum VNS measured after 48 hrs,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,510000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,510.0
16842,,,25040158,[],CHEMBL5244538,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922422,=,1,1,=,,IC50,ug.mL-1,,11.24,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,11.24
16843,,,25040161,[],CHEMBL5244539,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922422,=,1,1,=,,IC50,ug.mL-1,,11.24,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,ug ml-1,UO_0000274,,11.24
16844,,,25040163,[],CHEMBL5244540,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.26,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,55300.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,55.3
16845,,,25040165,[],CHEMBL5244541,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum W2,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.13,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,74600.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,74.6
16846,,,25040167,[],CHEMBL5244542,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Palo Alto,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.27,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,54100.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,54.1
16847,,,25040169,[],CHEMBL5244543,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum FCR3,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.23,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,58600.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,58.6
16848,,,25040171,[],CHEMBL5244544,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Bres1,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.12,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,75000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,75.0
16849,,,25040174,[],CHEMBL5244545,Antiplasmodial activity against synchronized Plasmodium falciparum CS2,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.23,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,59000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,59.0
16850,,,25040177,[],CHEMBL5244546,Antiplasmodial activity against asynchronous Plasmodium falciparum CS2,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.26,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,55000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,55.0
16851,,,25040180,[],CHEMBL5244547,Antiplasmodial activity against synchronized Plasmodium falciparum 3D7,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.26,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,55000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,55.0
16852,,,25040183,[],CHEMBL5244548,Antiplasmodial activity against asynchronous Plasmodium falciparum 3D7,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.18,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,66000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,66.0
16853,,,25040186,[],CHEMBL5244549,Antiplasmodial activity against synchronized Plasmodium falciparum K1,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.17,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,67000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,67.0
16854,,,25040189,[],CHEMBL5244550,Antiplasmodial activity against asynchronous Plasmodium falciparum K1,F,,,BAO_0000190,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244209,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,4.27,0,http://www.openphacts.org/units/Nanomolar,3922422,=,1,1,=,,IC50,nM,,54000.0,CHEMBL364,Plasmodium falciparum,Plasmodium falciparum,5833.0,,,IC50,uM,UO_0000065,,54.0
16855,,,25040756,[],CHEMBL5244794,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 by two fold broth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3922813,=,1,1,=,,MIC,nM,,20.89,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,nM,UO_0000065,,20.89
16856,,,25040769,[],CHEMBL5244796,Antibacterial activity against methicillin-resistant Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922813,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,8.0
16857,,,25040779,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244798,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 1 measured after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922813,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
16858,,,25040784,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244799,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 2 measured after 18 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922813,=,1,1,=,,MIC,ug.mL-1,,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.78
16859,,,25040831,[],CHEMBL5244807,Antimicrobial activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of microbial growth,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922813,<,1,1,<,,MIC,ug.mL-1,,0.016,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.016
16860,,,25040839,[],CHEMBL5244808,Bactericidal activity against methicillin-resistant Staphylococcus aureus assessed as inhibition of microbial growth,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244218,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922813,=,1,0,=,,MBC,ug ml-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,4.0
16861,,,25040897,[],CHEMBL5244824,Antibacterial activity against Escherichia coli ATCC 700603 assessed as bacterial growth inhibition by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
16862,,,25040943,[],CHEMBL5244826,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.1
16863,,,25041060,[],CHEMBL5244841,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,,MIC,ug.mL-1,,0.0625,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.0625
16864,,,25041165,[],CHEMBL5244867,Antibacterial activity against Escherichia coli JM109 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
16865,,,25041189,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5244873,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 24 hrs by agar streak dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,,MIC,ug.mL-1,,6.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,6.25
16866,,,25041205,[],CHEMBL5244874,Antibacterial activity against Escherichia coli NCDC 134 assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,25.0
16867,,,25041248,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '18.0'}]",CHEMBL5244875,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 18 hrs by twofold serial dilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
16868,,,25041268,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Lower', 'standard_units': 'hrs', 'standard_value': '18.0', 'text_value': None, 'type': 'TIME_Lower', 'units': 'hrs', 'value': '18.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME_Upper', 'standard_units': 'hrs', 'standard_value': '20.0', 'text_value': None, 'type': 'TIME_Upper', 'units': 'hrs', 'value': '20.0'}]",CHEMBL5244878,Antibacterial activity against Escherichia coli assessed as bacterial growth inhibition incubated for 18 to 20 hrs by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244219,Eur J Med Chem,2018.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3922897,=,1,1,=,,MIC,ug.mL-1,,0.31,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.31
16869,,,25051320,"[{'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hrs', 'value': '24.0'}]",CHEMBL5247440,Antibacterial activity against norfloxacin resistant Staphylococcus aureus 1199B overexpressing NorA assessed as bacterial growth inhibition incubated for 24 hrs by resazurin based microdilution assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244281,Bioorg Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3926529,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
16870,,,25051413,[],CHEMBL5247484,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1199B overexpressing NorA gene assessed as bacterial growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5244281,Bioorg Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,3926529,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
16871,,,25082597,[],CHEMBL5256154,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 by serial microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5252638,RSC Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3932051,=,1,1,=,,MIC,nM,,12100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,uM,UO_0000065,,12.1
16872,,,25082809,[],CHEMBL5256218,Antimicrobial activity against Staphylococcus aureus ATCC 6538 P FDA 209P by serial microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5252638,RSC Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3932051,=,1,1,=,,MIC,nM,,7500.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,uM,UO_0000065,,7.5
16873,,,25082816,[],CHEMBL5256219,Antimicrobial activity against Bacillus cereus ATCC 10702 NCTC 8035 by serial microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5252638,RSC Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3932051,=,1,1,=,,MIC,nM,,24400.0,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MIC,uM,UO_0000065,,24.4
16874,,,25082822,[],CHEMBL5256220,Antimicrobial activity against Enterococcus faecalis ATCC 29212 by serial microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5252638,RSC Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3932051,=,1,1,=,,MIC,nM,,24400.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,uM,UO_0000065,,24.4
16875,,,25082828,[],CHEMBL5256221,Antimicrobial activity against Escherichia coli ATCC 25922 by serial microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5252638,RSC Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3932051,=,1,1,=,,MIC,nM,,4700.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,uM,UO_0000065,,4.7
16876,,,25082835,[],CHEMBL5256222,Bactericidal against Staphylococcus aureus ATCC 6538 P FDA 209P by serial microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5252638,RSC Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Micromolar,3932051,=,1,0,=,,MBC,uM,,7.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,uM,UO_0000064,,7.5
16877,,,25082839,[],CHEMBL5256223,Bactericidal activity against Bacillus cereus ATCC 10702 NCTC 8035 by serial microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5252638,RSC Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Micromolar,3932051,=,1,0,=,,MBC,uM,,24.4,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,,MBC,uM,UO_0000064,,24.4
16878,,,25082845,[],CHEMBL5256224,Bactericidal activity against Enterococcus faecalis ATCC 29212 by serial microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5252638,RSC Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Micromolar,3932051,=,1,0,=,,MBC,uM,,24.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MBC,uM,UO_0000064,,24.4
16879,,,25082851,[],CHEMBL5256225,Bactericidal activity against Escherichia coli ATCC 25922 by serial microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5252638,RSC Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Micromolar,3932051,=,1,0,=,,MBC,uM,,24.4,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MBC,uM,UO_0000064,,24.4
16880,,,25082853,[],CHEMBL5256226,Bactericidal against Pseudomonas aeruginosa ATCC 9027 by serial microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5252638,RSC Med Chem,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Micromolar,3932051,=,1,0,=,,MBC,uM,,49.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MBC,uM,UO_0000064,,49.0
16881,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25117892,[],CHEMBL5291828,"Compound was evaluated for inhibition of human KCNH2 in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL240,Homo sapiens,HERG,9606.0,,,AC50,uM,UO_0000065,,30.0
16882,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25119602,[],CHEMBL5291755,Compound was evaluated for inhibition of rat Cacna1c in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3762,Rattus norvegicus,Voltage-gated L-type calcium channel alpha-1C subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
16883,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25120621,[],CHEMBL5291805,Binding affinity towards rat Grin1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL330,Rattus norvegicus,Glutamate (NMDA) receptor subunit zeta 1,10116.0,,,AC50,uM,UO_0000065,,10.0
16884,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25121794,[],CHEMBL5291740,Compound was evaluated for inhibition of human ADRB1 in an in vitro assay measured by radioactivity method,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16885,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25122881,[],CHEMBL5291742,Binding affinity towards human ADRB2 in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16886,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25123969,[],CHEMBL5291890,Binding affinity towards human SLC6A3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
16887,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25126114,[],CHEMBL5291770,Binding affinity towards human CHRNA4 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1882,Homo sapiens,Neuronal acetylcholine receptor protein alpha-4 subunit,9606.0,,,AC50,uM,UO_0000065,,10.0
16888,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25127023,[],CHEMBL5291722,"Compound was evaluated for inhibition of human ABCB11 in an in vitro assay with cellular components measured by filtration, liquid scintillation counting",F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,300000.0,CHEMBL6020,Homo sapiens,Bile salt export pump,9606.0,,,AC50,uM,UO_0000065,,300.0
16889,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25128044,[],CHEMBL5291798,Binding affinity towards rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
16890,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25129438,[],CHEMBL5291853,"Binding affinity towards human OPRK1 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16891,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25130612,[],CHEMBL5291801,Compound was evaluated for inhibition of rat Gabra1 in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL343,Rattus norvegicus,GABA receptor alpha-1 subunit,10116.0,,,AC50,uM,UO_0000065,,10.0
16892,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25131824,[],CHEMBL5291823,Binding affinity towards human HTR2C in an in vitro assay with cellular components measured by radioactivity method,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
16893,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25133024,[],CHEMBL5291724,Binding affinity towards human ADORA1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16894,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25134228,[],CHEMBL5291727,Binding affinity towards human ADORA3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16895,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25135470,[],CHEMBL5291763,Compound was evaluated for inhibition of human CHRM1 in an in vitro assay with cellular components measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,AC50,uM,UO_0000065,,10.0
16896,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25136703,[],CHEMBL5291767,Binding affinity towards human CHRM3 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,AC50,uM,UO_0000065,,30.0
16897,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25137939,[],CHEMBL5291732,Binding affinity towards human ADRA1A in an in vitro assay with cellular components (NIBR assay) measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16898,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25140351,[],CHEMBL5291781,"Binding affinity towards human DRD2 in an in vitro assay with cellular components measured by membrane filtration, scintillation proximity assay",B,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16899,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25141555,[],CHEMBL5291880,Binding affinity towards human SLC29A1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1997,Homo sapiens,Equilibrative nucleoside transporter 1,9606.0,,,AC50,uM,UO_0000065,,10.0
16900,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25143718,[],CHEMBL5291737,Binding affinity towards human ADRA2B in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16901,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25145019,[],CHEMBL5291891,Binding affinity towards human SLC6A2 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
16902,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25147893,[],CHEMBL5291738,Compound was evaluated for inhibition of human ADRA2C in an in vitro assay with cellular components measured by membrane filtration,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16903,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25149140,[],CHEMBL5291824,"Compound was evaluated for inhibition of human HTR3A in an in vitro assay with cellular components measured by membrane filtration, radioactivity method",F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL1899,Homo sapiens,Serotonin 3a (5-HT3a) receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
16904,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25150352,[],CHEMBL5291892,Binding affinity towards human SLC6A4 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,AC50,uM,UO_0000065,,10.0
16905,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25152497,[],CHEMBL5291726,Binding affinity towards human ADORA2A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16906,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25154085,[],CHEMBL5291852,Binding affinity towards human OPRD1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
16907,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25155216,[],CHEMBL5291889,Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2069,Homo sapiens,Thromboxane A2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16908,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25157459,[],CHEMBL5291894,Binding affinity towards human OPRM1 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
16909,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25159697,[],CHEMBL5291895,Compound was evaluated for inhibition of human MAOA in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,AC50,uM,UO_0000065,,10.0
16910,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25162136,[],CHEMBL5291750,Binding affinity towards human AVPR1A in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16911,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25163277,[],CHEMBL5291751,Binding affinity towards human AVPR2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1790,Homo sapiens,Vasopressin V2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16912,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25166211,[],CHEMBL5291870,Compound was evaluated for inhibition of human PTGS2 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,AC50,uM,UO_0000065,,10.0
16913,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25167325,[],CHEMBL5291791,Binding affinity towards human ESR1 in an in vitro cell free assay (NIBR assay) measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,AC50,uM,UO_0000065,,10.0
16914,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25169352,[],CHEMBL5291810,Agonist activity at human HRH2 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16915,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25170467,[],CHEMBL5291753,Binding affinity towards human BDKRB2 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16916,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25172771,[],CHEMBL5291803,Binding affinity towards human GHSR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL4616,Homo sapiens,Ghrelin receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16917,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25174415,[],CHEMBL5291868,Compound was evaluated for inhibition of rat Ptgs1 in an in vitro cell free assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL4042,Rattus norvegicus,Cyclooxygenase-1,10116.0,,,AC50,uM,UO_0000065,,10.0
16918,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25175860,[],CHEMBL5291850,"Binding affinity towards human NR3C1 in an in vitro cell free assay measured by filtration, radioactivity method",B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16919,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25177007,[],CHEMBL5291744,Binding affinity towards human AGTR1 in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL227,Homo sapiens,Type-1 angiotensin II receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16920,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25178223,[],CHEMBL5291757,Binding affinity towards human CCKAR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16921,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25180537,[],CHEMBL5291777,Agonist activity at human DRD1 in an in vitro cell-based assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16922,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25181635,[],CHEMBL5291773,Binding affinity towards human CNR1 in an in vitro assay with cellular components measured by membrane filtration,B,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16923,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25183416,[],CHEMBL5291831,Binding affinity towards human MC3R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,AC50,uM,UO_0000065,,10.0
16924,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25184420,[],CHEMBL5291832,Binding affinity towards human MC4R in an in vitro assay with cellular components measured by scintillation proximity assay in vitro assay with cellular components,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,AC50,uM,UO_0000065,,10.0
16925,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25185344,[],CHEMBL5291858,Compound was evaluated for inhibition of human PDE4D in an in vitro cell free assay measured by scintillation proximity assay,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL288,Homo sapiens,Phosphodiesterase 4D,9606.0,,,AC50,uM,UO_0000065,,30.0
16926,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25186532,[],CHEMBL5291834,Binding affinity towards human NPY1R in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,AC50,uM,UO_0000065,,10.0
16927,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25187461,[],CHEMBL5291748,Binding affinity towards rat Ar in an in vitro cell free assay measured by fluorescence polarization method,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,AC50,uM,UO_0000065,,10.0
16928,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25188189,[],CHEMBL5291846,Binding affinity towards human NR1I2 in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL3401,Homo sapiens,Pregnane X receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16929,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25189203,[],CHEMBL5291833,Binding affinity towards human MLNR in an in vitro assay with cellular components measured by scintillation proximity assay,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL2203,Homo sapiens,Motilin receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16930,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25190709,[],CHEMBL5291898,Compound was evaluated for inhibition of human PDE3A in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL241,Homo sapiens,Phosphodiesterase 3A,9606.0,,,AC50,uM,UO_0000065,,30.0
16931,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25193544,[],CHEMBL5291899,Binding affinity towards human DRD3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
16932,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25200609,[],CHEMBL5291921,Binding affinity towards human HRH3 in an in vitro assay with cellular components measured by scintillation counting,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL264,Homo sapiens,Histamine H3 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16933,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25212529,[],CHEMBL5291809,Binding affinity towards human HRH1 in an in vitro assay measured by filtration,B,,,BAO_0000186,BAO_0000357,single protein format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16934,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25213754,[],CHEMBL5291765,Antagonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
16935,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25214957,[],CHEMBL5291764,Agonist activity at human CHRM2 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,AC50,uM,UO_0000065,,10.0
16936,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25217034,[],CHEMBL5291813,Agonist activity at human HTR1A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL214,Homo sapiens,Serotonin 1a (5-HT1a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16937,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25218083,[],CHEMBL5291901,Antagonist activity at human ADRA1A in an in vitro cell-based assay measured by fluorescence spectroscopy,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
16938,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25219909,[],CHEMBL5291735,Antagonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16939,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25221104,[],CHEMBL5291734,Agonist activity at human ADRA2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16940,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25222153,[],CHEMBL5291861,Antagonist activity at human PGR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16941,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25223051,[],CHEMBL5291860,Agonist activity at human PGR in an in vitro cell free assay measured by time-resolved fluorescence resonance energy transfer method,F,,,BAO_0000186,BAO_0000019,assay format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL208,Homo sapiens,Progesterone receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16942,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25225187,[],CHEMBL5291817,Antagonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16943,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25226353,[],CHEMBL5291816,Agonist activity at human HTR2A in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16944,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25227539,[],CHEMBL5291821,Antagonist activity at human HTR2B in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16945,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25228731,[],CHEMBL5291819,Agonist activity at human HTR2B in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,10000.0,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,AC50,uM,UO_0000065,,10.0
16946,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25229824,[],CHEMBL5291729,Agonist activity at human ADRA1A in an in vitro cell-based assay (NIBR assay) measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL229,Homo sapiens,Alpha-1a adrenergic receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
16947,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25230755,[],CHEMBL5291772,Antagonist activity at human CNR1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
16948,,"Summarised AC50 (mean value for measurements with a relation sign ""=""; largest value for measurements with relation sign "">"")",25231640,[],CHEMBL5291771,Agonist activity at human CNR1 in an in vitro cell-based assay measured by fluorescent imaging plate reader,F,,,BAO_0000186,BAO_0000219,cell-based format,CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21,,,CHEMBL5291721,Nat Commun,2023.0,,CHEMBL9,NORFLOXACIN,CHEMBL9,,0,http://www.openphacts.org/units/Nanomolar,3940805,>,1,1,>,,AC50,nM,,30000.0,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,AC50,uM,UO_0000065,,30.0
16949,,,37906,[],CHEMBL873322,Antibacterial activity against Klebsiella ozaenae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.0381
16950,,,37907,[],CHEMBL700135,Antibacterial activity against Klebsiella pneumoniae,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16951,,,37908,[],CHEMBL802305,Antibacterial activity against Shigella sonnei,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL614595,Shigella sonnei,Shigella sonnei,624.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16952,,,37909,[],CHEMBL804813,Antibacterial activity against Shigella boydii,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL614395,Shigella boydii,Shigella boydii,621.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16953,,,37910,[],CHEMBL766966,Antibacterial activity against Plesiomonas shigelloides,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.019,CHEMBL614405,Plesiomonas shigelloides,Plesiomonas shigelloides,703.0,,,MIC,ug ml-1,UO_0000274,,0.019
16954,,,37911,[],CHEMBL879669,Antibacterial activity against Morganella morganii,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL614443,Morganella morganii,Morganella morganii,582.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16955,,,37912,[],CHEMBL809474,Antibacterial activity against Staphylococcus aureus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16956,,,37913,[],CHEMBL770155,Antibacterial activity against Pseudomonas aeruginosa,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0381,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.0381
16957,,,37914,[],CHEMBL813506,Antibacterial activity against Vibrio mimicus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL612621,Vibrio mimicus,Vibrio mimicus,674.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16958,,,37915,[],CHEMBL813499,Antibacterial activity against Vibrio fluvialis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL614602,Vibrio fluvialis,Vibrio fluvialis,676.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16959,,,37916,[],CHEMBL816175,Antibacterial activity against Vibrio cholerae 0139,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16960,,,37917,[],CHEMBL816174,Antibacterial activity against Vibrio cholerae 01,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL614402,Vibrio cholerae,Vibrio cholerae,666.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16961,,,37918,[],CHEMBL813512,Antibacterial activity against Vibrio parahaemolyticus,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL614403,Vibrio parahaemolyticus,Vibrio parahaemolyticus,670.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16962,,,37919,[],CHEMBL674714,Antibacterial activity against Escherichia coli NCTC 10418,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.019,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.019
16963,,,37920,[],CHEMBL675405,Antibacterial activity against Edwardsiella tarda,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL614598,Edwardsiella tarda,Edwardsiella tarda,636.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16964,,,37921,[],CHEMBL857812,Antibacterial activity against Proteus vulgaris,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.019,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.019
16965,,,37922,[],CHEMBL765014,Antibacterial activity against Proteus mirabilis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16966,,,37923,[],CHEMBL803305,Antibacterial activity against Salmonella Typhimurium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16967,,,37924,[],CHEMBL801481,Antibacterial activity against Salmonella paratyphi A,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.019,CHEMBL612293,Salmonella enterica subsp. enterica serovar Paratyphi A,Salmonella paratyphi,54388.0,,,MIC,ug ml-1,UO_0000274,,0.019
16968,,,37925,[],CHEMBL799645,Antibacterial activity against Klebsiella ozaenae Salmonella typhi,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.019,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,0.019
16969,,,37926,[],CHEMBL803218,Antibacterial activity against Salmonella enteritidis,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL614447,Salmonella enterica subsp. enterica serovar Enteritidis,Salmonella enteritidis,149539.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16970,,,37927,[],CHEMBL657688,Antibacterial activity against Citrobacter ferundii,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16971,,,37928,[],CHEMBL679746,Antibacterial activity against Enterobacter,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.019,CHEMBL614439,Enterobacter,Enterobacter,547.0,,,MIC,ug ml-1,UO_0000274,,0.019
16972,,,37929,[],CHEMBL649198,Antibacterial activity against Bacillus megatherium,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1138695,Bioorg Med Chem Lett,2004.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,350597,=,1,1,=,,MIC,ug.mL-1,,0.0095,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,,MIC,ug ml-1,UO_0000274,,0.0095
16973,,,54116,[],CHEMBL688000,Lowest concentration necessary to induce DNA gyrase-mediated cleavage of DNA,B,,,BAO_0002752,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,1,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,0,=,,Concentration,ug ml-1,,0.5,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,Concentration,ug ml-1,UO_0000274,,0.5
16974,,,54117,[],CHEMBL689081,Concentration required for 50% inhibition of gyrase.,B,,,BAO_0002752,BAO_0000223,protein complex format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,0,=,,Concentration,ug ml-1,,5.3,CHEMBL2094139,Escherichia coli,DNA gyrase,562.0,,,Concentration,ug ml-1,UO_0000274,,5.3
16975,,,54118,[],CHEMBL677348,Minimum inhibitory concentration against Escherichia coli (H560),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,0.025,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.025
16976,,,54119,[],CHEMBL677349,Minimum inhibitory concentration against Escherichia coli (vogel),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.05
16977,,,54120,[],CHEMBL700973,Minimum inhibitory concentration against Klebsiella pneumoniae (MGH-2),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.1
16978,,,54121,[],CHEMBL772086,Minimum inhibitory concentration against Providencia rettgeri. (M1771),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,0.1,CHEMBL612537,Providencia rettgeri,Providencia rettgeri,587.0,,,MIC,ug ml-1,UO_0000274,,0.1
16979,,,54122,[],CHEMBL682405,Minimum inhibitory concentration against Enterobacter cloacae. (MA2446).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,0.05,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.05
16980,,,54123,[],CHEMBL763460,Minimum inhibitory concentration against Pseudomonas aeruginosa. (UI-18),F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,0.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,0.4
16981,,,54124,[],CHEMBL809590,Minimum inhibitory concentration against Staphylococcus aureus (H-228).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,3.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,3.1
16982,,,54125,[],CHEMBL810411,Minimum inhibitory concentration against Staphylococcus aureus (UC76).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.2
16983,,,54126,[],CHEMBL882117,Minimum inhibitory concentration against Streptococcus faecalis (MGH-2).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,,MIC,ug ml-1,UO_0000274,,0.8
16984,,,54127,[],CHEMBL811346,Minimum inhibitory concentration against Streptococcus pneumoniae (SV-1).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,1.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.6
16985,,,54128,[],CHEMBL809189,Minimum inhibitory concentration against Streptococcus pyogenes (C203).,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,0.8,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.8
16986,,,54129,[],CHEMBL821621,Minimum inhibitory concentration against gram-negative enterobacteriaceae.,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,223,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614439,Enterobacter,Enterobacter,547.0,,,MIC,ug ml-1,UO_0000274,,0.06
16987,,,54130,[],CHEMBL742309,In vivo activity against Escherichia coli (po),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,223,=,1,0,=,,PD50,mg kg-1,,1.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,1.0
16988,,,54131,[],CHEMBL857253,In vivo activity against Escherichia coli (sc),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,223,=,1,0,=,,PD50,mg kg-1,,0.3,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,0.3
16989,,,54132,[],CHEMBL738927,In vivo activity against Pseudomonas aeruginosa (po),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,223,=,1,0,=,,PD50,mg kg-1,,25.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,25.0
16990,,,54133,[],CHEMBL738928,In vivo activity against Pseudomonas aeruginosa (sc),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,223,=,1,0,=,,PD50,mg kg-1,,5.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,5.0
16991,,,54134,[],CHEMBL738931,In vivo activity against Streptococcus pyogenes (po),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,223,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
16992,,,54135,[],CHEMBL738932,In vivo activity against Streptococcus pyogenes (sc),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,223,=,1,0,=,,PD50,mg kg-1,,20.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,20.0
16993,,,54136,[],CHEMBL738929,In vivo activity against Streptococcus pneumoniae (po),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,223,>,1,0,>,,PD50,mg kg-1,,100.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,100.0
16994,,,54137,[],CHEMBL738930,In vivo activity against Streptococcus pneumoniae (sc),F,,,BAO_0000179,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1124223,J Med Chem,1988.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,,223,=,1,0,=,,PD50,mg kg-1,,29.0,CHEMBL375,Mus musculus,Mus musculus,10090.0,,,PD50,mg kg-1,UO_0000308,,29.0
16995,,,59554,[],CHEMBL674723,Antibacterial activity tested against Escherichia coli ATCC 8739,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
16996,,,59555,[],CHEMBL676416,Antibacterial activity tested against Escherichia coli ISF 432,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.015
16997,,,59556,[],CHEMBL679044,Antibacterial activity tested against Enterobacter cloacae OMNFI 174,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.015
16998,,,59557,[],CHEMBL765244,Antibacterial activity tested against Proteus vulgaris CNUR 5,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,0.5
16999,,,59558,[],CHEMBL767635,Antibacterial activity tested against Providencia stuartii CNUR 5,F,,,BAO_0002146,BAO_0000218,organism-based format,O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O,,,CHEMBL1129660,J Med Chem,1996.0,,CHEMBL8,CIPROFLOXACIN,CHEMBL8,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,267402,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614445,Providencia stuartii,Providencia stuartii,588.0,,,MIC,ug ml-1,UO_0000274,,0.06
